2. PATHOGENS
Basic Information
Accession number
GCA_001045395.1
Release date
2015-07-02
Organism
Salmonella enterica subsp. enterica serovar Paratyphi A
Species name
Salmonella enterica
Assembly level
Chromosome
Assembly name
ASM104539v1
Assembly submitter
Third Military Medical University
Assembly Type
haploid
Genome size
4.6 Mb
GC percent
52.0
Contig count
1
Collection date
1955
Sample location
China:Beijing
Host
Homo sapiens
Isolation source
feces
Isolate type
-
Strain
CMCC50093
Isolate
-
ARG List
ORF_ID Pass_Bitscore Best_Hit_Bitscore Best_Hit_ARO Best_Identities ARO Model_type SNPs_in_Best_Hit_ARO Other_SNPs Drug class Resistance mechanism AMR gene family Description
CP011967.1_114 # 136073 # 137017 500.0 584.334 leuO 87.26 ARO:3003843 protein homolog model nucleoside antibiotic; disinfecting agents and antiseptics antibiotic efflux major facilitator superfamily (MFS) antibiotic efflux pump leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression. LeuO is also an activator of the MdtNOP efflux pump.
CP011967.1_384 # 454005 # 457118 1900.0 2020.36 acrD 94.21 ARO:3000491 protein homolog model aminoglycoside antibiotic antibiotic efflux resistance-nodulation-cell division (RND) antibiotic efflux pump AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
CP011967.1_556 # 634677 # 636323 400.0 712.22 ArnT 62.43 ARO:3005053 protein homolog model peptide antibiotic antibiotic target alteration pmr phosphoethanolamine transferase ArnT is involved in Cell Wall Biosynthesis, specifically 4-amino-4-deoxy-L-arabinose (Ara4N). It confers resistance to peptide antibiotics.
CP011967.1_559 # 639195 # 640178 550.0 588.571 PmrF 87.42 ARO:3003578 protein homolog model peptide antibiotic antibiotic target alteration pmr phosphoethanolamine transferase PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. pmrF corresponds to 1 locus in Pseudomonas aeruginosa PAO1 and 1 locus in Pseudomonas aeruginosa LESB58.
CP011967.1_725 # 813532 # 814254 450.0 469.544 baeR 96.67 ARO:3000828 protein homolog model aminoglycoside antibiotic; aminocoumarin antibiotic antibiotic efflux resistance-nodulation-cell division (RND) antibiotic efflux pump BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
CP011967.1_728 # 817063 # 820143 1800.0 1855.11 mdtC 91.51 ARO:3000794 protein homolog model aminocoumarin antibiotic antibiotic efflux resistance-nodulation-cell division (RND) antibiotic efflux pump MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity. mdtC corresponds to 3 loci in Pseudomonas aeruginosa PAO1 (gene name: muxC/muxB) and 3 loci in Pseudomonas aeruginosa LESB58.
CP011967.1_729 # 820144 # 823266 1800.0 1862.43 mdtB 91.44 ARO:3000793 protein homolog model aminocoumarin antibiotic antibiotic efflux resistance-nodulation-cell division (RND) antibiotic efflux pump MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.
CP011967.1_784 # 886497 # 887663 700.0 710.294 ugd 88.14 ARO:3003577 protein homolog model peptide antibiotic antibiotic target alteration pmr phosphoethanolamine transferase PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin.
CP011967.1_903 # 997841 # 998563 470.0 501.516 sdiA 99.17 ARO:3000826 protein homolog model fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics antibiotic efflux resistance-nodulation-cell division (RND) antibiotic efflux pump SdiA is a cell division regulator that is also a positive regulator of AcrAB only when it's expressed from a plasmid. When the sdiA gene is on the chromosome, it has no effect on expression of acrAB.
CP011967.1_1226 # 1323170 # 1323607 275.0 302.368 AAC(6')-Iy 98.62 ARO:3002569 protein homolog model aminoglycoside antibiotic antibiotic inactivation AAC(6') AAC(6')-Iy is a chromosomal-encoded aminoglycoside acetyltransferase in S. enteritidis and S. enterica. Regulatory mutation required to increase expression of this chromosomally-encoded gene for resistance. In the specific system, aminoglycoside resistance was due to a transcriptional fusion secondary to a chromosomal deletion in which the downstream aac(6')-Iy gene was placed under the control of the upstream nmpC promoter.
CP011967.1_1315 # 1419430 # 1419813 230.0 251.136 marA 95.24 ARO:3000263 protein homolog model fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics antibiotic efflux; reduced permeability to antibiotic resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.
CP011967.1_1353 # 1451665 # 1452027 150.0 175.252 Klebsiella pneumoniae KpnE 76.67 ARO:3004580 protein homolog model macrolide antibiotic; aminoglycoside antibiotic; cephalosporin; tetracycline antibiotic; peptide antibiotic; rifamycin antibiotic; disinfecting agents and antiseptics antibiotic efflux small multidrug resistance (SMR) antibiotic efflux pump KpnE subunit of KpnEF resembles EbrAB from E. coli. Mutation in KpnEF resulted in increased susceptibility to cefepime, ceftriaxon, colistin, erythromycin, rifampin, tetracycline, and streptomycin as well as enhanced sensitivity toward sodium dodecyl sulfate, deoxycholate, dyes, benzalkonium chloride, chlorhexidine, and triclosan.
CP011967.1_1785 # 1880307 # 1882055 1000.0 1159.05 msbA 96.22 ARO:3003950 protein homolog model nitroimidazole antibiotic antibiotic efflux ATP-binding cassette (ABC) antibiotic efflux pump MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.
CP011967.1_1868 # 1971233 # 1972465 700.0 722.62 Escherichia coli mdfA 87.68 ARO:3001328 protein homolog model tetracycline antibiotic; disinfecting agents and antiseptics antibiotic efflux major facilitator superfamily (MFS) antibiotic efflux pump Multidrug efflux pump in E. coli. This multidrug efflux system was originally identified as the Cmr/CmlA chloramphenicol exporter.
CP011967.1_2007 # 2123527 # 2124204 400.0 423.705 kdpE 91.96 ARO:3003841 protein homolog model aminoglycoside antibiotic antibiotic efflux kdpDE kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.
CP011967.1_2212 # 2339847 # 2341040 670.0 694.115 Escherichia coli acrA 91.44 ARO:3004043 protein homolog model fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics antibiotic efflux resistance-nodulation-cell division (RND) antibiotic efflux pump AcrA is a subunit of the AcrAB-TolC multidrug efflux system found in E. coli.
CP011967.1_2213 # 2341063 # 2344212 1900.0 1999.94 acrB 94.47 ARO:3000216 protein homolog model fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics antibiotic efflux resistance-nodulation-cell division (RND) antibiotic efflux pump Protein subunit of AcrA-AcrB-TolC multidrug efflux complex. AcrB functions as a herterotrimer which forms the inner membrane component and is primarily responsible for substrate recognition and energy transduction by acting as a drug/proton antiporter.
CP011967.1_2651 # 2776948 # 2777478 280.0 337.806 emrR 93.14 ARO:3000516 protein homolog model fluoroquinolone antibiotic antibiotic efflux major facilitator superfamily (MFS) antibiotic efflux pump EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
CP011967.1_2652 # 2777605 # 2778777 675.0 705.286 emrA 89.74 ARO:3000027 protein homolog model fluoroquinolone antibiotic antibiotic efflux major facilitator superfamily (MFS) antibiotic efflux pump EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.
CP011967.1_2653 # 2778794 # 2780332 900.0 994.571 emrB 95.7 ARO:3000074 protein homolog model fluoroquinolone antibiotic antibiotic efflux major facilitator superfamily (MFS) antibiotic efflux pump emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.
CP011967.1_2659 # 2786372 # 2786557 100.0 109.383 rsmA 85.25 ARO:3005069 protein homolog model fluoroquinolone antibiotic; diaminopyrimidine antibiotic; phenicol antibiotic antibiotic efflux resistance-nodulation-cell division (RND) antibiotic efflux pump rsmA is a gene that regulates virulence of Pseudomonas aeruginosa. However, its negative effect on MexEF-OprN overexpression has been noted to confer resistance to various antibiotics. It's Escherichia coli homolog is csrA.
CP011967.1_3039 # 3181026 # 3181847 500.0 531.176 bacA 96.7 ARO:3002986 protein homolog model peptide antibiotic antibiotic target alteration undecaprenyl pyrophosphate related proteins The bacA gene product (BacA) recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin.
CP011967.1_3289 # 3422035 # 3422667 400.0 430.254 CRP 98.1 ARO:3000518 protein homolog model macrolide antibiotic; fluoroquinolone antibiotic; penam antibiotic efflux resistance-nodulation-cell division (RND) antibiotic efflux pump CRP is a global regulator that represses MdtEF multidrug efflux pump expression.
CP011967.1_3861 # 4046412 # 4047785 890.0 908.286 cpxA 96.94 ARO:3000830 protein homolog model aminoglycoside antibiotic; aminocoumarin antibiotic antibiotic efflux resistance-nodulation-cell division (RND) antibiotic efflux pump CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
CP011967.1_121 # 143230 # 144996 500.0 589.726 Haemophilus influenzae PBP3 conferring resistance to beta-lactam antibiotics 53.08 ARO:3004446 protein variant model D350N, S357N cephalosporin; cephamycin; penam antibiotic target alteration Penicillin-binding protein mutations conferring resistance to beta-lactam antibiotics PBP3 is a penicillin-binding protein and beta-lactam resistance enzyme encoded by the ftsI gene in Haemophilus influenzae. Mutations in ftsI confer resistance to beta-lactam antibiotics.
CP011967.1_574 # 655305 # 656663 850.0 892.878 Escherichia coli GlpT with mutation conferring resistance to fosfomycin 96.68 ARO:3003889 protein variant model E448K phosphonic acid antibiotic antibiotic target alteration antibiotic-resistant GlpT Point mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.
CP011967.1_3268 # 3404689 # 3405873 700.0 796.579 Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin 99.49 ARO:3003369 protein variant model R234F elfamycin antibiotic antibiotic target alteration elfamycin resistant EF-Tu Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin.
CP011967.1_3935 # 4134232 # 4135416 700.0 796.579 Escherichia coli EF-Tu mutants conferring resistance to Pulvomycin 99.49 ARO:3003369 protein variant model R234F elfamycin antibiotic antibiotic target alteration elfamycin resistant EF-Tu Sequence variants of Escherichia coli elongation factor Tu that confer resistance to Pulvomycin.
CP011967.1_1314 # 1418976 # 1419410 210.0 273.478 Escherichia coli AcrAB-TolC with MarR mutations conferring resistance to ciprofloxacin and tetracycline 92.36 ARO:3003378 protein overexpression model fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics antibiotic target alteration; antibiotic efflux resistance-nodulation-cell division (RND) antibiotic efflux pump MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.
CP011967.1_2211 # 2339052 # 2339705 375.0 394.815 Escherichia coli AcrAB-TolC with AcrR mutation conferring resistance to ciprofloxacin, tetracycline, and ceftazidime 87.38 ARO:3003807 protein overexpression model fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics antibiotic target alteration; antibiotic efflux resistance-nodulation-cell division (RND) antibiotic efflux pump AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.
CP011967.1_4028 # 4255894 # 4256217 200.0 212.231 Escherichia coli soxS with mutation conferring antibiotic resistance 95.33 ARO:3003511 protein overexpression model fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; glycylcycline; cephamycin; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; penem; disinfecting agents and antiseptics antibiotic target alteration; antibiotic efflux; reduced permeability to antibiotic ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump; General Bacterial Porin with reduced permeability to beta-lactams SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.
CP011967.1_4029 # 4256304 # 4256762 300.0 300.056 Escherichia coli soxR with mutation conferring antibiotic resistance 96.05 ARO:3003381 protein overexpression model fluoroquinolone antibiotic; cephalosporin; glycylcycline; penam; tetracycline antibiotic; rifamycin antibiotic; phenicol antibiotic; disinfecting agents and antiseptics antibiotic target alteration; antibiotic efflux ATP-binding cassette (ABC) antibiotic efflux pump; major facilitator superfamily (MFS) antibiotic efflux pump; resistance-nodulation-cell division (RND) antibiotic efflux pump SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.
VF List
Query_id %Identity E-value Related genes VF ID Virulence factor VFcategory VFcategoryID Characteristics Description Strain
CP011967.1_133 77.303 0.0 lpxC VF0044 LOS Immune modulation VFC0258 Lic1A (phosphorylcholine (ChoP) kinase) 5'-CAAT-3' within the 5'-end of its coding sequence; lic2A, also referred to as lexA, variation in the number of 5'-CAAT-3' repeats has been shown to correlate directly with phase variation of the Gal-alpha(1-4)beta-Gal LPS structure; But lgtC (glycosyltransferase), another phase-variable gene, ultimately dictates whether this structure is synthesized. lic3A encode a sialyl transferase which directs the substitution of LPS with sialic acid. (lpxC) UDP-3-O-(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase [LOS (VF0044) - Immune modulation (VFC0258)] [Haemophilus influenzae Rd KW20] Haemophilus influenzae
CP011967.1_231 64.201 5.76E-159 lpxD VF0044 LOS Immune modulation VFC0258 Lic1A (phosphorylcholine (ChoP) kinase) 5'-CAAT-3' within the 5'-end of its coding sequence; lic2A, also referred to as lexA, variation in the number of 5'-CAAT-3' repeats has been shown to correlate directly with phase variation of the Gal-alpha(1-4)beta-Gal LPS structure; But lgtC (glycosyltransferase), another phase-variable gene, ultimately dictates whether this structure is synthesized. lic3A encode a sialyl transferase which directs the substitution of LPS with sialic acid. (lpxD) UDP-3-O-(3-hydroxymyristoyl) glucosamine N-acyltransferase [LOS (VF0044) - Immune modulation (VFC0258)] [Haemophilus influenzae Rd KW20] Haemophilus influenzae
CP011967.1_233 67.939 4.76E-131 lpxA VF0044 LOS Immune modulation VFC0258 Lic1A (phosphorylcholine (ChoP) kinase) 5'-CAAT-3' within the 5'-end of its coding sequence; lic2A, also referred to as lexA, variation in the number of 5'-CAAT-3' repeats has been shown to correlate directly with phase variation of the Gal-alpha(1-4)beta-Gal LPS structure; But lgtC (glycosyltransferase), another phase-variable gene, ultimately dictates whether this structure is synthesized. lic3A encode a sialyl transferase which directs the substitution of LPS with sialic acid. (lpxA) UDP-N-acetylglucosamine acyltransferase [LOS (VF0044) - Immune modulation (VFC0258)] [Haemophilus influenzae Rd KW20] Haemophilus influenzae
CP011967.1_234 64.456 5.96E-178 lpxB VF0044 LOS Immune modulation VFC0258 Lic1A (phosphorylcholine (ChoP) kinase) 5'-CAAT-3' within the 5'-end of its coding sequence; lic2A, also referred to as lexA, variation in the number of 5'-CAAT-3' repeats has been shown to correlate directly with phase variation of the Gal-alpha(1-4)beta-Gal LPS structure; But lgtC (glycosyltransferase), another phase-variable gene, ultimately dictates whether this structure is synthesized. lic3A encode a sialyl transferase which directs the substitution of LPS with sialic acid. (lpxB) lipid-A-disaccharide synthase [LOS (VF0044) - Immune modulation (VFC0258)] [Haemophilus influenzae Rd KW20] Haemophilus influenzae
CP011967.1_250 68.266 6.41E-128 IlpA VF0513 IlpA Adherence VFC0001 (IlpA) immunogenic lipoprotein A [IlpA (VF0513) - Adherence (VFC0001)] [Vibrio vulnificus YJ016] Vibrio vulnificus
CP011967.1_270 65.445 1.05E-90 algU VF0091 Alginate Biofilm VFC0271 Alginate production is frequently referred to as mucoidy because colonies producing alginate have a wet glistening (mucoid) appearance, which is very different from that of colonies not producing alginate; most of the alginate biosynthetic genes are clustered in the algD operon; Alginate production is highly regulated. Regulatory genes are located in two areas far removed from the biosynthetic genes, with one exception algC (algU) alginate biosynthesis protein AlgZ/FimS [Alginate (VF0091) - Biofilm (VFC0271)] [Pseudomonas aeruginosa PAO1] Pseudomonas aeruginosa
CP011967.1_344 95.486 0.0 sinH VF0400 SinH Adherence VFC0001 N-terminal 350 residues exhibits homology with invasin of Yersinia pseudotuberculosis (49.5% identity) and intimin of E. coli O111 (enteropathogenic E. coli) (48% identity). The amino termini of invasin and intimin serve as membrane-spanning anchors in the bacterial outer membrane. (sinH) intimin-like protein [SinH (VF0400) - Adherence (VFC0001)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_345 98.056 0.0 sinH VF0400 SinH Adherence VFC0001 N-terminal 350 residues exhibits homology with invasin of Yersinia pseudotuberculosis (49.5% identity) and intimin of E. coli O111 (enteropathogenic E. coli) (48% identity). The amino termini of invasin and intimin serve as membrane-spanning anchors in the bacterial outer membrane. (sinH) intimin-like protein [SinH (VF0400) - Adherence (VFC0001)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_346 98.413 1.1E-38 sinH VF0400 SinH Adherence VFC0001 N-terminal 350 residues exhibits homology with invasin of Yersinia pseudotuberculosis (49.5% identity) and intimin of E. coli O111 (enteropathogenic E. coli) (48% identity). The amino termini of invasin and intimin serve as membrane-spanning anchors in the bacterial outer membrane. (sinH) intimin-like protein [SinH (VF0400) - Adherence (VFC0001)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_349 75.0 1.81E-56 ratB VF0399 RatB Adherence VFC0001 Three putative intestinal colonization factors SinH, RatB and ShdA, are located in the same 25-kb pathogenicity island, called CS54. This island is present only in subspecies 1 of S. enterica. (ratB) putative outer membrane protein [RatB (VF0399) - Adherence (VFC0001)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_350 85.552 0.0 ratB VF0399 RatB Adherence VFC0001 Three putative intestinal colonization factors SinH, RatB and ShdA, are located in the same 25-kb pathogenicity island, called CS54. This island is present only in subspecies 1 of S. enterica. (ratB) putative outer membrane protein [RatB (VF0399) - Adherence (VFC0001)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_384 65.029 0.0 acrB VF0568 AcrAB Antimicrobial activity/Competitive advantage VFC0325 (acrB) acriflavine resistance protein B [AcrAB (VF0568) - Antimicrobial activity/Competitive advantage (VFC0325)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] Klebsiella pneumoniae
CP011967.1_460 71.474 4.94E-172 pla VF0139 Pla Exoenzyme VFC0251 Belongs to the family of OM proteases/adhesins known as omptins that share high sequence identity but differ in biological function; Omptins appear to constitute a unique class of proteases. Other omptin family outer membrane proteases include PgtE from S. enterica, OmpT and OmpR from E. coli, and SopA/IcsP from S. flexneri. Their catalytic residues are conserved. They require the presence of rough LPS for enzymatic activity and are inhibited by the O-antigen chains present in smooth LPS; unique to Y. pestis encoded by the pPCP1 plasmid not present in the enteropathogenic yersiniae Y. pseudotuberculosis and Y. enterocolitica (pla) plasminogen activator protease precursor [Pla (VF0139) - Exoenzyme (VFC0251)] [Yersinia pestis CO92] Yersinia pestis
CP011967.1_464 73.973 5.56E-34 gtrB VF0124 LPS Immune modulation VFC0258 Composed of the O-antigen, core polysaccharides and lipid A; the genes involved in the biosynthesis of the basic O-antigen are located in the rfb/rfc loci; O-antigen modification is associated with temperate bacteriophages. Four different serotype-converting phages have been found: SfII, Sf6, SfV and SfX, which are involved in conversion of a serotype Y stain to serotypes 2a, 3b, 5a and X, respectively (gtrB) bactoprenol glucosyl transferase [LPS (VF0124) - Immune modulation (VFC0258)] [Shigella flexneri 2a str. 301] Shigella flexneri
CP011967.1_465 72.34 7.54E-49 gtrA VF0124 LPS Immune modulation VFC0258 Composed of the O-antigen, core polysaccharides and lipid A; the genes involved in the biosynthesis of the basic O-antigen are located in the rfb/rfc loci; O-antigen modification is associated with temperate bacteriophages. Four different serotype-converting phages have been found: SfII, Sf6, SfV and SfX, which are involved in conversion of a serotype Y stain to serotypes 2a, 3b, 5a and X, respectively (gtrA) bactoprenol-linked glucose translocase/flippase [LPS (VF0124) - Immune modulation (VFC0258)] [Shigella flexneri 2a str. 301] Shigella flexneri
CP011967.1_570 93.06 0.0 sseL VF0947 TTSS-2 secreted effectors Effector delivery system VFC0086 (sseL) type III secretion system effector SseL, deubiquitinase [TTSS-2 secreted effectors (VF0947) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_587 97.685 5.01E-154 rcsB VF0571 RcsAB Regulation VFC0301 (rcsB) transcriptional regulator RcsB [RcsAB (VF0571) - Regulation (VFC0301)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] Klebsiella pneumoniae
CP011967.1_706 95.495 6.17E-76 steD VF0947 TTSS-2 secreted effectors Effector delivery system VFC0086 (steD) type III secretion system effector SteD [TTSS-2 secreted effectors (VF0947) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_739 64.644 0.0 KP1_RS17340 VF0560 Capsule Immune modulation VFC0258 The Klebsiella polysaccharide capsule is produced through a Wzy-dependent process, for which the synthesis and export machinery are encoded in a single 10-30 kb region of the genome known as the K locus.; 78 distinct capsule phenotypes have been recognized by serological typing, but many isolates are serologically non-typable.; capsular serotypes vary substantially in the degree of serum resistance; K1, K2 and K5 are highly serum resistant and are associated with hypervirulent strains that differ from classical K. pneumoniae in that they commonly cause community-acquired disease. (KP1_RS17340) polysaccharide export protein [Capsule (VF0560) - Immune modulation (VFC0258)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] Klebsiella pneumoniae
CP011967.1_748 88.649 0.0 gmd VF0560 Capsule Immune modulation VFC0258 The Klebsiella polysaccharide capsule is produced through a Wzy-dependent process, for which the synthesis and export machinery are encoded in a single 10-30 kb region of the genome known as the K locus.; 78 distinct capsule phenotypes have been recognized by serological typing, but many isolates are serologically non-typable.; capsular serotypes vary substantially in the degree of serum resistance; K1, K2 and K5 are highly serum resistant and are associated with hypervirulent strains that differ from classical K. pneumoniae in that they commonly cause community-acquired disease. (gmd) GDP-mannose 4,6-dehydratase [Capsule (VF0560) - Immune modulation (VFC0258)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] Klebsiella pneumoniae
CP011967.1_749 76.803 0.0 KP1_RS17305 VF0560 Capsule Immune modulation VFC0258 The Klebsiella polysaccharide capsule is produced through a Wzy-dependent process, for which the synthesis and export machinery are encoded in a single 10-30 kb region of the genome known as the K locus.; 78 distinct capsule phenotypes have been recognized by serological typing, but many isolates are serologically non-typable.; capsular serotypes vary substantially in the degree of serum resistance; K1, K2 and K5 are highly serum resistant and are associated with hypervirulent strains that differ from classical K. pneumoniae in that they commonly cause community-acquired disease. (KP1_RS17305) GDP-L-fucose synthase [Capsule (VF0560) - Immune modulation (VFC0258)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] Klebsiella pneumoniae
CP011967.1_751 60.442 0.0 KP1_RS17295 VF0560 Capsule Immune modulation VFC0258 The Klebsiella polysaccharide capsule is produced through a Wzy-dependent process, for which the synthesis and export machinery are encoded in a single 10-30 kb region of the genome known as the K locus.; 78 distinct capsule phenotypes have been recognized by serological typing, but many isolates are serologically non-typable.; capsular serotypes vary substantially in the degree of serum resistance; K1, K2 and K5 are highly serum resistant and are associated with hypervirulent strains that differ from classical K. pneumoniae in that they commonly cause community-acquired disease. (KP1_RS17295) glycosyltransferase WbuB [Capsule (VF0560) - Immune modulation (VFC0258)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] Klebsiella pneumoniae
CP011967.1_752 62.076 0.0 KP1_RS17280 VF0560 Capsule Immune modulation VFC0258 The Klebsiella polysaccharide capsule is produced through a Wzy-dependent process, for which the synthesis and export machinery are encoded in a single 10-30 kb region of the genome known as the K locus.; 78 distinct capsule phenotypes have been recognized by serological typing, but many isolates are serologically non-typable.; capsular serotypes vary substantially in the degree of serum resistance; K1, K2 and K5 are highly serum resistant and are associated with hypervirulent strains that differ from classical K. pneumoniae in that they commonly cause community-acquired disease. (KP1_RS17280) mannose-1-phosphate guanylyltransferase/mannose-6-phosphate isomerase [Capsule (VF0560) - Immune modulation (VFC0258)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] Klebsiella pneumoniae
CP011967.1_753 75.824 0.0 rfbK1 VF0560 Capsule Immune modulation VFC0258 The Klebsiella polysaccharide capsule is produced through a Wzy-dependent process, for which the synthesis and export machinery are encoded in a single 10-30 kb region of the genome known as the K locus.; 78 distinct capsule phenotypes have been recognized by serological typing, but many isolates are serologically non-typable.; capsular serotypes vary substantially in the degree of serum resistance; K1, K2 and K5 are highly serum resistant and are associated with hypervirulent strains that differ from classical K. pneumoniae in that they commonly cause community-acquired disease. (rfbK1) O9 family phosphomannomutase RfbK1 [Capsule (VF0560) - Immune modulation (VFC0258)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] Klebsiella pneumoniae
CP011967.1_754 62.228 3.87E-176 wcaJ VF0560 Capsule Immune modulation VFC0258 The Klebsiella polysaccharide capsule is produced through a Wzy-dependent process, for which the synthesis and export machinery are encoded in a single 10-30 kb region of the genome known as the K locus.; 78 distinct capsule phenotypes have been recognized by serological typing, but many isolates are serologically non-typable.; capsular serotypes vary substantially in the degree of serum resistance; K1, K2 and K5 are highly serum resistant and are associated with hypervirulent strains that differ from classical K. pneumoniae in that they commonly cause community-acquired disease. (wcaJ) undecaprenyl-phosphate glucose phosphotransferase [Capsule (VF0560) - Immune modulation (VFC0258)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] Klebsiella pneumoniae
CP011967.1_760 94.375 1.54E-111 galF VF0560 Capsule Immune modulation VFC0258 The Klebsiella polysaccharide capsule is produced through a Wzy-dependent process, for which the synthesis and export machinery are encoded in a single 10-30 kb region of the genome known as the K locus.; 78 distinct capsule phenotypes have been recognized by serological typing, but many isolates are serologically non-typable.; capsular serotypes vary substantially in the degree of serum resistance; K1, K2 and K5 are highly serum resistant and are associated with hypervirulent strains that differ from classical K. pneumoniae in that they commonly cause community-acquired disease. (galF) GalU regulator GalF [Capsule (VF0560) - Immune modulation (VFC0258)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] Klebsiella pneumoniae
CP011967.1_761 89.922 2.44E-84 galF VF0560 Capsule Immune modulation VFC0258 The Klebsiella polysaccharide capsule is produced through a Wzy-dependent process, for which the synthesis and export machinery are encoded in a single 10-30 kb region of the genome known as the K locus.; 78 distinct capsule phenotypes have been recognized by serological typing, but many isolates are serologically non-typable.; capsular serotypes vary substantially in the degree of serum resistance; K1, K2 and K5 are highly serum resistant and are associated with hypervirulent strains that differ from classical K. pneumoniae in that they commonly cause community-acquired disease. (galF) GalU regulator GalF [Capsule (VF0560) - Immune modulation (VFC0258)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] Klebsiella pneumoniae
CP011967.1_762 62.573 2.18E-159 rffG VF0044 LOS Immune modulation VFC0258 Lic1A (phosphorylcholine (ChoP) kinase) 5'-CAAT-3' within the 5'-end of its coding sequence; lic2A, also referred to as lexA, variation in the number of 5'-CAAT-3' repeats has been shown to correlate directly with phase variation of the Gal-alpha(1-4)beta-Gal LPS structure; But lgtC (glycosyltransferase), another phase-variable gene, ultimately dictates whether this structure is synthesized. lic3A encode a sialyl transferase which directs the substitution of LPS with sialic acid. (rffG) dTDP-glucose 46-dehydratase [LOS (VF0044) - Immune modulation (VFC0258)] [Haemophilus influenzae Rd KW20] Haemophilus influenzae
CP011967.1_764 62.759 1.38E-140 wbtL VF0542 LPS Immune modulation VFC0258 The structure of Francisella spp. lipid A is unique in that it is modified by various carbohydrates that greatly reduce TLR4 activation and allow for immune evasion (wbtL) glucose-1-phosphate thymidylyltransferase [LPS (VF0542) - Immune modulation (VFC0258)] [Francisella tularensis subsp. tularensis SCHU S4] Francisella tularensis
CP011967.1_767 79.377 4.0E-162 rfbF VF0392 O-antigen Immune modulation VFC0258 Clinical Y. enterocolitica isolates from humans predominantly belong to serotypes O:3, O:9, O:8 and O:5,27; Y. enterocolitica O antigen expression is temperature regulated. (rfbF) glucose-1-phosphate cytidylyltransferase [O-antigen (VF0392) - Immune modulation (VFC0258)] [Yersinia enterocolitica subsp. enterocolitica 8081] Yersinia enterocolitica
CP011967.1_768 69.663 0.0 rfbG VF0392 O-antigen Immune modulation VFC0258 Clinical Y. enterocolitica isolates from humans predominantly belong to serotypes O:3, O:9, O:8 and O:5,27; Y. enterocolitica O antigen expression is temperature regulated. (rfbG) CDP-glucose 4,6-dehydratase [O-antigen (VF0392) - Immune modulation (VFC0258)] [Yersinia enterocolitica subsp. enterocolitica 8081] Yersinia enterocolitica
CP011967.1_783 95.299 0.0 gndA VF0560 Capsule Immune modulation VFC0258 The Klebsiella polysaccharide capsule is produced through a Wzy-dependent process, for which the synthesis and export machinery are encoded in a single 10-30 kb region of the genome known as the K locus.; 78 distinct capsule phenotypes have been recognized by serological typing, but many isolates are serologically non-typable.; capsular serotypes vary substantially in the degree of serum resistance; K1, K2 and K5 are highly serum resistant and are associated with hypervirulent strains that differ from classical K. pneumoniae in that they commonly cause community-acquired disease. (gndA) NADP-dependent phosphogluconate dehydrogenase [Capsule (VF0560) - Immune modulation (VFC0258)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] Klebsiella pneumoniae
CP011967.1_784 82.216 0.0 ugd VF0560 Capsule Immune modulation VFC0258 The Klebsiella polysaccharide capsule is produced through a Wzy-dependent process, for which the synthesis and export machinery are encoded in a single 10-30 kb region of the genome known as the K locus.; 78 distinct capsule phenotypes have been recognized by serological typing, but many isolates are serologically non-typable.; capsular serotypes vary substantially in the degree of serum resistance; K1, K2 and K5 are highly serum resistant and are associated with hypervirulent strains that differ from classical K. pneumoniae in that they commonly cause community-acquired disease. (ugd) UDP-glucose 6-dehydrogenase [Capsule (VF0560) - Immune modulation (VFC0258)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] Klebsiella pneumoniae
CP011967.1_798 95.692 0.0 sopA VF0949 TTSS-1 secreted effectors Effector delivery system VFC0086 (sopA) type III secretion system effector SopA, HECT-like E3 ubiquitin ligase [TTSS-1 secreted effectors (VF0949) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_799 94.152 2.31E-110 sopA VF0949 TTSS-1 secreted effectors Effector delivery system VFC0086 (sopA) type III secretion system effector SopA, HECT-like E3 ubiquitin ligase [TTSS-1 secreted effectors (VF0949) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_800 92.157 5.45E-26 sopA VF0949 TTSS-1 secreted effectors Effector delivery system VFC0086 (sopA) type III secretion system effector SopA, HECT-like E3 ubiquitin ligase [TTSS-1 secreted effectors (VF0949) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_872 65.217 1.71E-99 rcsA VF0571 RcsAB Regulation VFC0301 (rcsA) transcriptional activator for ctr capsule biosynthesis [RcsAB (VF0571) - Regulation (VFC0301)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] Klebsiella pneumoniae
CP011967.1_873 65.891 2.28E-103 fliR VF0394 Flagella Motility VFC0204 (fliR) flagellar biosynthetic protein FliR [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] Yersinia enterocolitica
CP011967.1_874 74.157 2.47E-36 fliQ VF0394 Flagella Motility VFC0204 (fliQ) flagellar biosynthetic protein FliQ [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] Yersinia enterocolitica
CP011967.1_875 85.217 3.71E-140 fliP VF0394 Flagella Motility VFC0204 (fliP) flagellar biosynthetic protein FliP [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] Yersinia enterocolitica
CP011967.1_877 76.812 7.21E-71 fliN VF0394 Flagella Motility VFC0204 (fliN) flagellar motor switch protein FliN [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] Yersinia enterocolitica
CP011967.1_878 84.985 0.0 fliM VF0394 Flagella Motility VFC0204 (fliM) flagellar motor switch protein FliM [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] Yersinia enterocolitica
CP011967.1_882 83.7 0.0 fliI VF0394 Flagella Motility VFC0204 (fliI) flagellum-specific ATP synthase FliI [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] Yersinia enterocolitica
CP011967.1_884 83.283 0.0 fliG VF0394 Flagella Motility VFC0204 (fliG) flagellar motor switch protein G [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] Yersinia enterocolitica
CP011967.1_885 63.669 0.0 fliF VF0394 Flagella Motility VFC0204 (fliF) flagellar M-ring protein FliF [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] Yersinia enterocolitica
CP011967.1_892 71.875 9.53E-63 fliS VF0394 Flagella Motility VFC0204 (fliS) flagellar protein FliS [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] Yersinia enterocolitica
CP011967.1_897 83.193 5.21E-144 fliA VF0394 Flagella Motility VFC0204 (fliA) flagellar biosynthesis sigma factor [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] Yersinia enterocolitica
CP011967.1_922 75.862 5.28E-53 flhD VF0394 Flagella Motility VFC0204 (flhD) flagellar transcriptional activator FlhD [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] Yersinia enterocolitica
CP011967.1_923 81.865 1.31E-116 flhC VF0394 Flagella Motility VFC0204 (flhC) flagellar biosynthesis transcription activator FlhC [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] Yersinia enterocolitica
CP011967.1_924 83.051 0.0 motA VF0394 Flagella Motility VFC0204 (motA) flagellar motor protein MotA [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] Yersinia enterocolitica
CP011967.1_925 68.571 3.59E-154 motB VF0394 Flagella Motility VFC0204 (motB) flagellar motor protein MotB [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] Yersinia enterocolitica
CP011967.1_926 75.664 0.0 cheA VF0394 Flagella Motility VFC0204 (cheA) chemotaxis protein CheA [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] Yersinia enterocolitica
CP011967.1_927 85.0 2.26E-97 cheW VF0394 Flagella Motility VFC0204 (cheW) purine-binding chemotaxis protein CheW [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] Yersinia enterocolitica
CP011967.1_929 73.944 3.54E-152 cheR VF0394 Flagella Motility VFC0204 (cheR) chemotaxis methyltransferase CheR [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] Yersinia enterocolitica
CP011967.1_930 85.387 0.0 cheB VF0394 Flagella Motility VFC0204 (cheB) chemotaxis-specific methylesterase CheB [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] Yersinia enterocolitica
CP011967.1_931 90.698 5.38E-84 cheY VF0394 Flagella Motility VFC0204 (cheY) chemotaxis regulatory protein CheY [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] Yersinia enterocolitica
CP011967.1_932 78.641 5.68E-111 cheZ VF0394 Flagella Motility VFC0204 (cheZ) chemotaxis regulator CheZ [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] Yersinia enterocolitica
CP011967.1_934 65.789 0.0 flhB VF0394 Flagella Motility VFC0204 (flhB) flagellar biosynthetic protein FlhB [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] Yersinia enterocolitica
CP011967.1_935 85.507 0.0 flhA VF0394 Flagella Motility VFC0204 (flhA) flagellar biosynthesis protein FlhA [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] Yersinia enterocolitica
CP011967.1_950 60.494 6.26E-107 CBU_1566 VF0696 T4SS secreted effectors Effector delivery system VFC0086 (CBU_1566) Coxiella Dot/Icm type IVB secretion system translocated effector [T4SS secreted effectors (VF0696) - Effector delivery system (VFC0086)] [Coxiella burnetii RSA 493] Coxiella burnetii
CP011967.1_1000 96.667 5.14E-178 sopE2 VF0949 TTSS-1 secreted effectors Effector delivery system VFC0086 (sopE2) type III secretion system effector SopE2, guanine nucleotide exchange factor [TTSS-1 secreted effectors (VF0949) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1082 81.915 3.01E-178 kdsA VF0044 LOS Immune modulation VFC0258 Lic1A (phosphorylcholine (ChoP) kinase) 5'-CAAT-3' within the 5'-end of its coding sequence; lic2A, also referred to as lexA, variation in the number of 5'-CAAT-3' repeats has been shown to correlate directly with phase variation of the Gal-alpha(1-4)beta-Gal LPS structure; But lgtC (glycosyltransferase), another phase-variable gene, ultimately dictates whether this structure is synthesized. lic3A encode a sialyl transferase which directs the substitution of LPS with sialic acid. (kdsA) 2-dehydro-3-deoxyphosphooctonate aldolase [LOS (VF0044) - Immune modulation (VFC0258)] [Haemophilus influenzae Rd KW20] Haemophilus influenzae
CP011967.1_1098 75.347 1.15E-161 galU VF0044 LOS Immune modulation VFC0258 Lic1A (phosphorylcholine (ChoP) kinase) 5'-CAAT-3' within the 5'-end of its coding sequence; lic2A, also referred to as lexA, variation in the number of 5'-CAAT-3' repeats has been shown to correlate directly with phase variation of the Gal-alpha(1-4)beta-Gal LPS structure; But lgtC (glycosyltransferase), another phase-variable gene, ultimately dictates whether this structure is synthesized. lic3A encode a sialyl transferase which directs the substitution of LPS with sialic acid. (galU) glucosephosphate uridylyltransferase [LOS (VF0044) - Immune modulation (VFC0258)] [Haemophilus influenzae Rd KW20] Haemophilus influenzae
CP011967.1_1155 90.11 2.28E-120 steC VF0947 TTSS-2 secreted effectors Effector delivery system VFC0086 (steC) type III secretion system effector SteC (Salmonella translocated effector C), kinase [TTSS-2 secreted effectors (VF0947) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1156 91.273 0.0 steC VF0947 TTSS-2 secreted effectors Effector delivery system VFC0086 (steC) type III secretion system effector SteC (Salmonella translocated effector C), kinase [TTSS-2 secreted effectors (VF0947) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1164 99.291 1.48E-104 pltC VF0407 Typhoid toxin Exotoxin VFC0235 Classic cytolethal distending toxins (CDTs) are three component AB toxins, composed of CdtA, CdtB and CdtC. CdtA and CdtC mediate target cell binding and membrane translocation of CdtB, which then induces DNA damage, most probably through its nuclease activity; In the case of S. typhi, however, genes encoding CdtA and CdtC are absent. CdtB from S. typhi is produced with the pertussis-like toxins PltA and PltB only inside the host cell and is then secreted from the infected Cell in a PltA/B-Dependent manner and acts then as a classical CDT from outside;typhoid toxin seemed to have evolved from the combination of the activities of two exotoxin ancestors, CDT and pertussis toxins; The typhoid toxin is an atypical AB toxin encoded on SPI-11; The toxin is expressed exclusively when S. Typhi is intracellualr and localized within the Salmonella containing vacuole (SCV); Homologues are found in S. Paratyphi A and several NTS serovars, but are absent from S. Typhimurium and S. Enteritidis; The typhoid toxin is secreted within vesicles originating from the SCV and released into the extracellular space (pltC) an orphan pertussis-like toxin delivery subunit [Typhoid toxin (VF0407) - Exotoxin (VFC0235)] [Salmonella enterica subsp. enterica serovar Typhi str. CT18] Salmonella enterica (serovar typhi)
CP011967.1_1243 98.058 1.95E-149 sifB VF0947 TTSS-2 secreted effectors Effector delivery system VFC0086 (sifB) type III secretion system effector SifB (Salmonella induced filament protein B) [TTSS-2 secreted effectors (VF0947) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1262 89.048 1.58E-139 steA VF0948 TTSS effectors secreted via both systems Effector delivery system VFC0086 (steA) type III secretion system effector SteA (Salmonella translocated effector A) [TTSS effectors secreted via both systems (VF0948) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1403 68.063 6.4E-100 sodB VF0169 SodB Stress survival VFC0282 (sodB) superoxide dismutase [SodB (VF0169) - Stress survival (VFC0282)] [Legionella pneumophila subsp. pneumophila str. Philadelphia 1] Legionella pneumophila
CP011967.1_1411 99.716 0.0 ssaU VF0321 TTSS (SPI-2 encode) Effector delivery system VFC0086 SPI-2 T3SS effector repertoire varies greatly among different Salmonella serovars.; All serovars seem to have a set of 'core' effectors (SseF, SseG, PipB, SteA, SifA, SteD and PipB2), suggesting that they are critical for virulence in different hosts.; Another group of effectors (SseL, SifB, SopD2, SseJ, SteB, SteC, SlrP, and SseK2) always seem to be present in intestinal serovars but are frequently non-functional in extraintestinal or highly host-adapted serovars, suggesting these effectors contribute to virulence in the intestine, but not always in deeper tissues.;A further group of 'accessory' effectors (SspH2, SseK1, SrfJ, GtgA, GtgE, SseI, GogB, SteE, SseK3, SspH1, SpvB, SpvC, and SpvD) encoded on mobile genetic elements (MGEs) or DNA close to the remnants of MGEs are found sporadically across different serovars.;The only known effector genes in SPI-2, sseF and sseG, are likely to have conferred an early selective advantage to intracellular bacteria.;several sets of effectors that share high levels of sequence similarity. Examples of paralog effectors include Pathogenicity island-encoded protein B (PipB) and PipB2, which share 33% identity and 67% similarity, SifA and SifB that share 26% identity and 46% similarity, SopE and SopE2, which share 69% similarity, SopD and SopD2 that share 43% identity and 63% similarity. These effector protein paralogs often share structural similarity and/or biochemical activities but demonstrate functional divergence in intracellular localization and/or host protein targets or interaction partners. (ssaU) type III secretion system export apparatus switch protein SsaU [TTSS (SPI-2 encode) (VF0321) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1412 97.683 0.0 ssaT VF0321 TTSS (SPI-2 encode) Effector delivery system VFC0086 SPI-2 T3SS effector repertoire varies greatly among different Salmonella serovars.; All serovars seem to have a set of 'core' effectors (SseF, SseG, PipB, SteA, SifA, SteD and PipB2), suggesting that they are critical for virulence in different hosts.; Another group of effectors (SseL, SifB, SopD2, SseJ, SteB, SteC, SlrP, and SseK2) always seem to be present in intestinal serovars but are frequently non-functional in extraintestinal or highly host-adapted serovars, suggesting these effectors contribute to virulence in the intestine, but not always in deeper tissues.;A further group of 'accessory' effectors (SspH2, SseK1, SrfJ, GtgA, GtgE, SseI, GogB, SteE, SseK3, SspH1, SpvB, SpvC, and SpvD) encoded on mobile genetic elements (MGEs) or DNA close to the remnants of MGEs are found sporadically across different serovars.;The only known effector genes in SPI-2, sseF and sseG, are likely to have conferred an early selective advantage to intracellular bacteria.;several sets of effectors that share high levels of sequence similarity. Examples of paralog effectors include Pathogenicity island-encoded protein B (PipB) and PipB2, which share 33% identity and 67% similarity, SifA and SifB that share 26% identity and 46% similarity, SopE and SopE2, which share 69% similarity, SopD and SopD2 that share 43% identity and 63% similarity. These effector protein paralogs often share structural similarity and/or biochemical activities but demonstrate functional divergence in intracellular localization and/or host protein targets or interaction partners. (ssaT) type III secretion system minor export apparatus protein SsaT [TTSS (SPI-2 encode) (VF0321) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1413 100.0 7.18E-59 ssaS VF0321 TTSS (SPI-2 encode) Effector delivery system VFC0086 SPI-2 T3SS effector repertoire varies greatly among different Salmonella serovars.; All serovars seem to have a set of 'core' effectors (SseF, SseG, PipB, SteA, SifA, SteD and PipB2), suggesting that they are critical for virulence in different hosts.; Another group of effectors (SseL, SifB, SopD2, SseJ, SteB, SteC, SlrP, and SseK2) always seem to be present in intestinal serovars but are frequently non-functional in extraintestinal or highly host-adapted serovars, suggesting these effectors contribute to virulence in the intestine, but not always in deeper tissues.;A further group of 'accessory' effectors (SspH2, SseK1, SrfJ, GtgA, GtgE, SseI, GogB, SteE, SseK3, SspH1, SpvB, SpvC, and SpvD) encoded on mobile genetic elements (MGEs) or DNA close to the remnants of MGEs are found sporadically across different serovars.;The only known effector genes in SPI-2, sseF and sseG, are likely to have conferred an early selective advantage to intracellular bacteria.;several sets of effectors that share high levels of sequence similarity. Examples of paralog effectors include Pathogenicity island-encoded protein B (PipB) and PipB2, which share 33% identity and 67% similarity, SifA and SifB that share 26% identity and 46% similarity, SopE and SopE2, which share 69% similarity, SopD and SopD2 that share 43% identity and 63% similarity. These effector protein paralogs often share structural similarity and/or biochemical activities but demonstrate functional divergence in intracellular localization and/or host protein targets or interaction partners. (ssaS) type III secretion system minor export apparatus protein SsaS [TTSS (SPI-2 encode) (VF0321) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1414 100.0 1.64E-153 ssaR VF0321 TTSS (SPI-2 encode) Effector delivery system VFC0086 SPI-2 T3SS effector repertoire varies greatly among different Salmonella serovars.; All serovars seem to have a set of 'core' effectors (SseF, SseG, PipB, SteA, SifA, SteD and PipB2), suggesting that they are critical for virulence in different hosts.; Another group of effectors (SseL, SifB, SopD2, SseJ, SteB, SteC, SlrP, and SseK2) always seem to be present in intestinal serovars but are frequently non-functional in extraintestinal or highly host-adapted serovars, suggesting these effectors contribute to virulence in the intestine, but not always in deeper tissues.;A further group of 'accessory' effectors (SspH2, SseK1, SrfJ, GtgA, GtgE, SseI, GogB, SteE, SseK3, SspH1, SpvB, SpvC, and SpvD) encoded on mobile genetic elements (MGEs) or DNA close to the remnants of MGEs are found sporadically across different serovars.;The only known effector genes in SPI-2, sseF and sseG, are likely to have conferred an early selective advantage to intracellular bacteria.;several sets of effectors that share high levels of sequence similarity. Examples of paralog effectors include Pathogenicity island-encoded protein B (PipB) and PipB2, which share 33% identity and 67% similarity, SifA and SifB that share 26% identity and 46% similarity, SopE and SopE2, which share 69% similarity, SopD and SopD2 that share 43% identity and 63% similarity. These effector protein paralogs often share structural similarity and/or biochemical activities but demonstrate functional divergence in intracellular localization and/or host protein targets or interaction partners. (ssaR) type III secretion system minor export apparatus protein SsaR [TTSS (SPI-2 encode) (VF0321) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1415 98.447 0.0 ssaQ VF0321 TTSS (SPI-2 encode) Effector delivery system VFC0086 SPI-2 T3SS effector repertoire varies greatly among different Salmonella serovars.; All serovars seem to have a set of 'core' effectors (SseF, SseG, PipB, SteA, SifA, SteD and PipB2), suggesting that they are critical for virulence in different hosts.; Another group of effectors (SseL, SifB, SopD2, SseJ, SteB, SteC, SlrP, and SseK2) always seem to be present in intestinal serovars but are frequently non-functional in extraintestinal or highly host-adapted serovars, suggesting these effectors contribute to virulence in the intestine, but not always in deeper tissues.;A further group of 'accessory' effectors (SspH2, SseK1, SrfJ, GtgA, GtgE, SseI, GogB, SteE, SseK3, SspH1, SpvB, SpvC, and SpvD) encoded on mobile genetic elements (MGEs) or DNA close to the remnants of MGEs are found sporadically across different serovars.;The only known effector genes in SPI-2, sseF and sseG, are likely to have conferred an early selective advantage to intracellular bacteria.;several sets of effectors that share high levels of sequence similarity. Examples of paralog effectors include Pathogenicity island-encoded protein B (PipB) and PipB2, which share 33% identity and 67% similarity, SifA and SifB that share 26% identity and 46% similarity, SopE and SopE2, which share 69% similarity, SopD and SopD2 that share 43% identity and 63% similarity. These effector protein paralogs often share structural similarity and/or biochemical activities but demonstrate functional divergence in intracellular localization and/or host protein targets or interaction partners. (ssaQ) type III secretion system C ring protein SsaQ [TTSS (SPI-2 encode) (VF0321) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1416 99.194 1.1E-91 ssaP VF0321 TTSS (SPI-2 encode) Effector delivery system VFC0086 SPI-2 T3SS effector repertoire varies greatly among different Salmonella serovars.; All serovars seem to have a set of 'core' effectors (SseF, SseG, PipB, SteA, SifA, SteD and PipB2), suggesting that they are critical for virulence in different hosts.; Another group of effectors (SseL, SifB, SopD2, SseJ, SteB, SteC, SlrP, and SseK2) always seem to be present in intestinal serovars but are frequently non-functional in extraintestinal or highly host-adapted serovars, suggesting these effectors contribute to virulence in the intestine, but not always in deeper tissues.;A further group of 'accessory' effectors (SspH2, SseK1, SrfJ, GtgA, GtgE, SseI, GogB, SteE, SseK3, SspH1, SpvB, SpvC, and SpvD) encoded on mobile genetic elements (MGEs) or DNA close to the remnants of MGEs are found sporadically across different serovars.;The only known effector genes in SPI-2, sseF and sseG, are likely to have conferred an early selective advantage to intracellular bacteria.;several sets of effectors that share high levels of sequence similarity. Examples of paralog effectors include Pathogenicity island-encoded protein B (PipB) and PipB2, which share 33% identity and 67% similarity, SifA and SifB that share 26% identity and 46% similarity, SopE and SopE2, which share 69% similarity, SopD and SopD2 that share 43% identity and 63% similarity. These effector protein paralogs often share structural similarity and/or biochemical activities but demonstrate functional divergence in intracellular localization and/or host protein targets or interaction partners. (ssaP) type III secretion system needle length regulator SsaP [TTSS (SPI-2 encode) (VF0321) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1417 100.0 7.09E-88 ssaO VF0321 TTSS (SPI-2 encode) Effector delivery system VFC0086 SPI-2 T3SS effector repertoire varies greatly among different Salmonella serovars.; All serovars seem to have a set of 'core' effectors (SseF, SseG, PipB, SteA, SifA, SteD and PipB2), suggesting that they are critical for virulence in different hosts.; Another group of effectors (SseL, SifB, SopD2, SseJ, SteB, SteC, SlrP, and SseK2) always seem to be present in intestinal serovars but are frequently non-functional in extraintestinal or highly host-adapted serovars, suggesting these effectors contribute to virulence in the intestine, but not always in deeper tissues.;A further group of 'accessory' effectors (SspH2, SseK1, SrfJ, GtgA, GtgE, SseI, GogB, SteE, SseK3, SspH1, SpvB, SpvC, and SpvD) encoded on mobile genetic elements (MGEs) or DNA close to the remnants of MGEs are found sporadically across different serovars.;The only known effector genes in SPI-2, sseF and sseG, are likely to have conferred an early selective advantage to intracellular bacteria.;several sets of effectors that share high levels of sequence similarity. Examples of paralog effectors include Pathogenicity island-encoded protein B (PipB) and PipB2, which share 33% identity and 67% similarity, SifA and SifB that share 26% identity and 46% similarity, SopE and SopE2, which share 69% similarity, SopD and SopD2 that share 43% identity and 63% similarity. These effector protein paralogs often share structural similarity and/or biochemical activities but demonstrate functional divergence in intracellular localization and/or host protein targets or interaction partners. (ssaO) type III secretion system stalk protein SsaO [TTSS (SPI-2 encode) (VF0321) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1418 99.538 0.0 ssaN VF0321 TTSS (SPI-2 encode) Effector delivery system VFC0086 SPI-2 T3SS effector repertoire varies greatly among different Salmonella serovars.; All serovars seem to have a set of 'core' effectors (SseF, SseG, PipB, SteA, SifA, SteD and PipB2), suggesting that they are critical for virulence in different hosts.; Another group of effectors (SseL, SifB, SopD2, SseJ, SteB, SteC, SlrP, and SseK2) always seem to be present in intestinal serovars but are frequently non-functional in extraintestinal or highly host-adapted serovars, suggesting these effectors contribute to virulence in the intestine, but not always in deeper tissues.;A further group of 'accessory' effectors (SspH2, SseK1, SrfJ, GtgA, GtgE, SseI, GogB, SteE, SseK3, SspH1, SpvB, SpvC, and SpvD) encoded on mobile genetic elements (MGEs) or DNA close to the remnants of MGEs are found sporadically across different serovars.;The only known effector genes in SPI-2, sseF and sseG, are likely to have conferred an early selective advantage to intracellular bacteria.;several sets of effectors that share high levels of sequence similarity. Examples of paralog effectors include Pathogenicity island-encoded protein B (PipB) and PipB2, which share 33% identity and 67% similarity, SifA and SifB that share 26% identity and 46% similarity, SopE and SopE2, which share 69% similarity, SopD and SopD2 that share 43% identity and 63% similarity. These effector protein paralogs often share structural similarity and/or biochemical activities but demonstrate functional divergence in intracellular localization and/or host protein targets or interaction partners. (ssaN) type III secretion system ATPase SsaN [TTSS (SPI-2 encode) (VF0321) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1419 99.559 0.0 ssaV VF0321 TTSS (SPI-2 encode) Effector delivery system VFC0086 SPI-2 T3SS effector repertoire varies greatly among different Salmonella serovars.; All serovars seem to have a set of 'core' effectors (SseF, SseG, PipB, SteA, SifA, SteD and PipB2), suggesting that they are critical for virulence in different hosts.; Another group of effectors (SseL, SifB, SopD2, SseJ, SteB, SteC, SlrP, and SseK2) always seem to be present in intestinal serovars but are frequently non-functional in extraintestinal or highly host-adapted serovars, suggesting these effectors contribute to virulence in the intestine, but not always in deeper tissues.;A further group of 'accessory' effectors (SspH2, SseK1, SrfJ, GtgA, GtgE, SseI, GogB, SteE, SseK3, SspH1, SpvB, SpvC, and SpvD) encoded on mobile genetic elements (MGEs) or DNA close to the remnants of MGEs are found sporadically across different serovars.;The only known effector genes in SPI-2, sseF and sseG, are likely to have conferred an early selective advantage to intracellular bacteria.;several sets of effectors that share high levels of sequence similarity. Examples of paralog effectors include Pathogenicity island-encoded protein B (PipB) and PipB2, which share 33% identity and 67% similarity, SifA and SifB that share 26% identity and 46% similarity, SopE and SopE2, which share 69% similarity, SopD and SopD2 that share 43% identity and 63% similarity. These effector protein paralogs often share structural similarity and/or biochemical activities but demonstrate functional divergence in intracellular localization and/or host protein targets or interaction partners. (ssaV) type III secretion system major export apparatus protein ssaV [TTSS (SPI-2 encode) (VF0321) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1420 97.541 4.45E-88 ssaM VF0321 TTSS (SPI-2 encode) Effector delivery system VFC0086 SPI-2 T3SS effector repertoire varies greatly among different Salmonella serovars.; All serovars seem to have a set of 'core' effectors (SseF, SseG, PipB, SteA, SifA, SteD and PipB2), suggesting that they are critical for virulence in different hosts.; Another group of effectors (SseL, SifB, SopD2, SseJ, SteB, SteC, SlrP, and SseK2) always seem to be present in intestinal serovars but are frequently non-functional in extraintestinal or highly host-adapted serovars, suggesting these effectors contribute to virulence in the intestine, but not always in deeper tissues.;A further group of 'accessory' effectors (SspH2, SseK1, SrfJ, GtgA, GtgE, SseI, GogB, SteE, SseK3, SspH1, SpvB, SpvC, and SpvD) encoded on mobile genetic elements (MGEs) or DNA close to the remnants of MGEs are found sporadically across different serovars.;The only known effector genes in SPI-2, sseF and sseG, are likely to have conferred an early selective advantage to intracellular bacteria.;several sets of effectors that share high levels of sequence similarity. Examples of paralog effectors include Pathogenicity island-encoded protein B (PipB) and PipB2, which share 33% identity and 67% similarity, SifA and SifB that share 26% identity and 46% similarity, SopE and SopE2, which share 69% similarity, SopD and SopD2 that share 43% identity and 63% similarity. These effector protein paralogs often share structural similarity and/or biochemical activities but demonstrate functional divergence in intracellular localization and/or host protein targets or interaction partners. (ssaM) type III secretion system protein SsaM [TTSS (SPI-2 encode) (VF0321) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1421 98.182 0.0 ssaL VF0321 TTSS (SPI-2 encode) Effector delivery system VFC0086 SPI-2 T3SS effector repertoire varies greatly among different Salmonella serovars.; All serovars seem to have a set of 'core' effectors (SseF, SseG, PipB, SteA, SifA, SteD and PipB2), suggesting that they are critical for virulence in different hosts.; Another group of effectors (SseL, SifB, SopD2, SseJ, SteB, SteC, SlrP, and SseK2) always seem to be present in intestinal serovars but are frequently non-functional in extraintestinal or highly host-adapted serovars, suggesting these effectors contribute to virulence in the intestine, but not always in deeper tissues.;A further group of 'accessory' effectors (SspH2, SseK1, SrfJ, GtgA, GtgE, SseI, GogB, SteE, SseK3, SspH1, SpvB, SpvC, and SpvD) encoded on mobile genetic elements (MGEs) or DNA close to the remnants of MGEs are found sporadically across different serovars.;The only known effector genes in SPI-2, sseF and sseG, are likely to have conferred an early selective advantage to intracellular bacteria.;several sets of effectors that share high levels of sequence similarity. Examples of paralog effectors include Pathogenicity island-encoded protein B (PipB) and PipB2, which share 33% identity and 67% similarity, SifA and SifB that share 26% identity and 46% similarity, SopE and SopE2, which share 69% similarity, SopD and SopD2 that share 43% identity and 63% similarity. These effector protein paralogs often share structural similarity and/or biochemical activities but demonstrate functional divergence in intracellular localization and/or host protein targets or interaction partners. (ssaL) type III secretion system gatekeeper SsaL [TTSS (SPI-2 encode) (VF0321) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1422 98.661 1.79E-167 ssaK VF0321 TTSS (SPI-2 encode) Effector delivery system VFC0086 SPI-2 T3SS effector repertoire varies greatly among different Salmonella serovars.; All serovars seem to have a set of 'core' effectors (SseF, SseG, PipB, SteA, SifA, SteD and PipB2), suggesting that they are critical for virulence in different hosts.; Another group of effectors (SseL, SifB, SopD2, SseJ, SteB, SteC, SlrP, and SseK2) always seem to be present in intestinal serovars but are frequently non-functional in extraintestinal or highly host-adapted serovars, suggesting these effectors contribute to virulence in the intestine, but not always in deeper tissues.;A further group of 'accessory' effectors (SspH2, SseK1, SrfJ, GtgA, GtgE, SseI, GogB, SteE, SseK3, SspH1, SpvB, SpvC, and SpvD) encoded on mobile genetic elements (MGEs) or DNA close to the remnants of MGEs are found sporadically across different serovars.;The only known effector genes in SPI-2, sseF and sseG, are likely to have conferred an early selective advantage to intracellular bacteria.;several sets of effectors that share high levels of sequence similarity. Examples of paralog effectors include Pathogenicity island-encoded protein B (PipB) and PipB2, which share 33% identity and 67% similarity, SifA and SifB that share 26% identity and 46% similarity, SopE and SopE2, which share 69% similarity, SopD and SopD2 that share 43% identity and 63% similarity. These effector protein paralogs often share structural similarity and/or biochemical activities but demonstrate functional divergence in intracellular localization and/or host protein targets or interaction partners. (ssaK) type III secretion system stator SsaK [TTSS (SPI-2 encode) (VF0321) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1423 98.795 1.96E-55 ssaX VF0321 TTSS (SPI-2 encode) Effector delivery system VFC0086 SPI-2 T3SS effector repertoire varies greatly among different Salmonella serovars.; All serovars seem to have a set of 'core' effectors (SseF, SseG, PipB, SteA, SifA, SteD and PipB2), suggesting that they are critical for virulence in different hosts.; Another group of effectors (SseL, SifB, SopD2, SseJ, SteB, SteC, SlrP, and SseK2) always seem to be present in intestinal serovars but are frequently non-functional in extraintestinal or highly host-adapted serovars, suggesting these effectors contribute to virulence in the intestine, but not always in deeper tissues.;A further group of 'accessory' effectors (SspH2, SseK1, SrfJ, GtgA, GtgE, SseI, GogB, SteE, SseK3, SspH1, SpvB, SpvC, and SpvD) encoded on mobile genetic elements (MGEs) or DNA close to the remnants of MGEs are found sporadically across different serovars.;The only known effector genes in SPI-2, sseF and sseG, are likely to have conferred an early selective advantage to intracellular bacteria.;several sets of effectors that share high levels of sequence similarity. Examples of paralog effectors include Pathogenicity island-encoded protein B (PipB) and PipB2, which share 33% identity and 67% similarity, SifA and SifB that share 26% identity and 46% similarity, SopE and SopE2, which share 69% similarity, SopD and SopD2 that share 43% identity and 63% similarity. These effector protein paralogs often share structural similarity and/or biochemical activities but demonstrate functional divergence in intracellular localization and/or host protein targets or interaction partners. (ssaX) type III secretion system base-pod connector [TTSS (SPI-2 encode) (VF0321) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1424 99.598 0.0 ssaJ VF0321 TTSS (SPI-2 encode) Effector delivery system VFC0086 SPI-2 T3SS effector repertoire varies greatly among different Salmonella serovars.; All serovars seem to have a set of 'core' effectors (SseF, SseG, PipB, SteA, SifA, SteD and PipB2), suggesting that they are critical for virulence in different hosts.; Another group of effectors (SseL, SifB, SopD2, SseJ, SteB, SteC, SlrP, and SseK2) always seem to be present in intestinal serovars but are frequently non-functional in extraintestinal or highly host-adapted serovars, suggesting these effectors contribute to virulence in the intestine, but not always in deeper tissues.;A further group of 'accessory' effectors (SspH2, SseK1, SrfJ, GtgA, GtgE, SseI, GogB, SteE, SseK3, SspH1, SpvB, SpvC, and SpvD) encoded on mobile genetic elements (MGEs) or DNA close to the remnants of MGEs are found sporadically across different serovars.;The only known effector genes in SPI-2, sseF and sseG, are likely to have conferred an early selective advantage to intracellular bacteria.;several sets of effectors that share high levels of sequence similarity. Examples of paralog effectors include Pathogenicity island-encoded protein B (PipB) and PipB2, which share 33% identity and 67% similarity, SifA and SifB that share 26% identity and 46% similarity, SopE and SopE2, which share 69% similarity, SopD and SopD2 that share 43% identity and 63% similarity. These effector protein paralogs often share structural similarity and/or biochemical activities but demonstrate functional divergence in intracellular localization and/or host protein targets or interaction partners. (ssaJ) type III secretion system inner MS ring protein SsaJ [TTSS (SPI-2 encode) (VF0321) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1425 100.0 2.94E-56 ssaI VF0321 TTSS (SPI-2 encode) Effector delivery system VFC0086 SPI-2 T3SS effector repertoire varies greatly among different Salmonella serovars.; All serovars seem to have a set of 'core' effectors (SseF, SseG, PipB, SteA, SifA, SteD and PipB2), suggesting that they are critical for virulence in different hosts.; Another group of effectors (SseL, SifB, SopD2, SseJ, SteB, SteC, SlrP, and SseK2) always seem to be present in intestinal serovars but are frequently non-functional in extraintestinal or highly host-adapted serovars, suggesting these effectors contribute to virulence in the intestine, but not always in deeper tissues.;A further group of 'accessory' effectors (SspH2, SseK1, SrfJ, GtgA, GtgE, SseI, GogB, SteE, SseK3, SspH1, SpvB, SpvC, and SpvD) encoded on mobile genetic elements (MGEs) or DNA close to the remnants of MGEs are found sporadically across different serovars.;The only known effector genes in SPI-2, sseF and sseG, are likely to have conferred an early selective advantage to intracellular bacteria.;several sets of effectors that share high levels of sequence similarity. Examples of paralog effectors include Pathogenicity island-encoded protein B (PipB) and PipB2, which share 33% identity and 67% similarity, SifA and SifB that share 26% identity and 46% similarity, SopE and SopE2, which share 69% similarity, SopD and SopD2 that share 43% identity and 63% similarity. These effector protein paralogs often share structural similarity and/or biochemical activities but demonstrate functional divergence in intracellular localization and/or host protein targets or interaction partners. (ssaI) type III secretion system inner rod protein SsaI [TTSS (SPI-2 encode) (VF0321) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1427 100.0 1.02E-47 ssaG VF0321 TTSS (SPI-2 encode) Effector delivery system VFC0086 SPI-2 T3SS effector repertoire varies greatly among different Salmonella serovars.; All serovars seem to have a set of 'core' effectors (SseF, SseG, PipB, SteA, SifA, SteD and PipB2), suggesting that they are critical for virulence in different hosts.; Another group of effectors (SseL, SifB, SopD2, SseJ, SteB, SteC, SlrP, and SseK2) always seem to be present in intestinal serovars but are frequently non-functional in extraintestinal or highly host-adapted serovars, suggesting these effectors contribute to virulence in the intestine, but not always in deeper tissues.;A further group of 'accessory' effectors (SspH2, SseK1, SrfJ, GtgA, GtgE, SseI, GogB, SteE, SseK3, SspH1, SpvB, SpvC, and SpvD) encoded on mobile genetic elements (MGEs) or DNA close to the remnants of MGEs are found sporadically across different serovars.;The only known effector genes in SPI-2, sseF and sseG, are likely to have conferred an early selective advantage to intracellular bacteria.;several sets of effectors that share high levels of sequence similarity. Examples of paralog effectors include Pathogenicity island-encoded protein B (PipB) and PipB2, which share 33% identity and 67% similarity, SifA and SifB that share 26% identity and 46% similarity, SopE and SopE2, which share 69% similarity, SopD and SopD2 that share 43% identity and 63% similarity. These effector protein paralogs often share structural similarity and/or biochemical activities but demonstrate functional divergence in intracellular localization and/or host protein targets or interaction partners. (ssaG) type III secretion system needle filament protein SsaG [TTSS (SPI-2 encode) (VF0321) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1428 99.127 4.24E-171 sseG VF0321 TTSS (SPI-2 encode) Effector delivery system VFC0086 SPI-2 T3SS effector repertoire varies greatly among different Salmonella serovars.; All serovars seem to have a set of 'core' effectors (SseF, SseG, PipB, SteA, SifA, SteD and PipB2), suggesting that they are critical for virulence in different hosts.; Another group of effectors (SseL, SifB, SopD2, SseJ, SteB, SteC, SlrP, and SseK2) always seem to be present in intestinal serovars but are frequently non-functional in extraintestinal or highly host-adapted serovars, suggesting these effectors contribute to virulence in the intestine, but not always in deeper tissues.;A further group of 'accessory' effectors (SspH2, SseK1, SrfJ, GtgA, GtgE, SseI, GogB, SteE, SseK3, SspH1, SpvB, SpvC, and SpvD) encoded on mobile genetic elements (MGEs) or DNA close to the remnants of MGEs are found sporadically across different serovars.;The only known effector genes in SPI-2, sseF and sseG, are likely to have conferred an early selective advantage to intracellular bacteria.;several sets of effectors that share high levels of sequence similarity. Examples of paralog effectors include Pathogenicity island-encoded protein B (PipB) and PipB2, which share 33% identity and 67% similarity, SifA and SifB that share 26% identity and 46% similarity, SopE and SopE2, which share 69% similarity, SopD and SopD2 that share 43% identity and 63% similarity. These effector protein paralogs often share structural similarity and/or biochemical activities but demonstrate functional divergence in intracellular localization and/or host protein targets or interaction partners. (sseG) type III secretion system effector SseG [TTSS (SPI-2 encode) (VF0321) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1429 97.308 0.0 sseF VF0321 TTSS (SPI-2 encode) Effector delivery system VFC0086 SPI-2 T3SS effector repertoire varies greatly among different Salmonella serovars.; All serovars seem to have a set of 'core' effectors (SseF, SseG, PipB, SteA, SifA, SteD and PipB2), suggesting that they are critical for virulence in different hosts.; Another group of effectors (SseL, SifB, SopD2, SseJ, SteB, SteC, SlrP, and SseK2) always seem to be present in intestinal serovars but are frequently non-functional in extraintestinal or highly host-adapted serovars, suggesting these effectors contribute to virulence in the intestine, but not always in deeper tissues.;A further group of 'accessory' effectors (SspH2, SseK1, SrfJ, GtgA, GtgE, SseI, GogB, SteE, SseK3, SspH1, SpvB, SpvC, and SpvD) encoded on mobile genetic elements (MGEs) or DNA close to the remnants of MGEs are found sporadically across different serovars.;The only known effector genes in SPI-2, sseF and sseG, are likely to have conferred an early selective advantage to intracellular bacteria.;several sets of effectors that share high levels of sequence similarity. Examples of paralog effectors include Pathogenicity island-encoded protein B (PipB) and PipB2, which share 33% identity and 67% similarity, SifA and SifB that share 26% identity and 46% similarity, SopE and SopE2, which share 69% similarity, SopD and SopD2 that share 43% identity and 63% similarity. These effector protein paralogs often share structural similarity and/or biochemical activities but demonstrate functional divergence in intracellular localization and/or host protein targets or interaction partners. (sseF) type III secretion system effector SseF [TTSS (SPI-2 encode) (VF0321) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1430 99.296 2.35E-105 sscB VF0321 TTSS (SPI-2 encode) Effector delivery system VFC0086 SPI-2 T3SS effector repertoire varies greatly among different Salmonella serovars.; All serovars seem to have a set of 'core' effectors (SseF, SseG, PipB, SteA, SifA, SteD and PipB2), suggesting that they are critical for virulence in different hosts.; Another group of effectors (SseL, SifB, SopD2, SseJ, SteB, SteC, SlrP, and SseK2) always seem to be present in intestinal serovars but are frequently non-functional in extraintestinal or highly host-adapted serovars, suggesting these effectors contribute to virulence in the intestine, but not always in deeper tissues.;A further group of 'accessory' effectors (SspH2, SseK1, SrfJ, GtgA, GtgE, SseI, GogB, SteE, SseK3, SspH1, SpvB, SpvC, and SpvD) encoded on mobile genetic elements (MGEs) or DNA close to the remnants of MGEs are found sporadically across different serovars.;The only known effector genes in SPI-2, sseF and sseG, are likely to have conferred an early selective advantage to intracellular bacteria.;several sets of effectors that share high levels of sequence similarity. Examples of paralog effectors include Pathogenicity island-encoded protein B (PipB) and PipB2, which share 33% identity and 67% similarity, SifA and SifB that share 26% identity and 46% similarity, SopE and SopE2, which share 69% similarity, SopD and SopD2 that share 43% identity and 63% similarity. These effector protein paralogs often share structural similarity and/or biochemical activities but demonstrate functional divergence in intracellular localization and/or host protein targets or interaction partners. (sscB) chaperone for sseF [TTSS (SPI-2 encode) (VF0321) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1431 99.275 7.9E-100 sseE VF0321 TTSS (SPI-2 encode) Effector delivery system VFC0086 SPI-2 T3SS effector repertoire varies greatly among different Salmonella serovars.; All serovars seem to have a set of 'core' effectors (SseF, SseG, PipB, SteA, SifA, SteD and PipB2), suggesting that they are critical for virulence in different hosts.; Another group of effectors (SseL, SifB, SopD2, SseJ, SteB, SteC, SlrP, and SseK2) always seem to be present in intestinal serovars but are frequently non-functional in extraintestinal or highly host-adapted serovars, suggesting these effectors contribute to virulence in the intestine, but not always in deeper tissues.;A further group of 'accessory' effectors (SspH2, SseK1, SrfJ, GtgA, GtgE, SseI, GogB, SteE, SseK3, SspH1, SpvB, SpvC, and SpvD) encoded on mobile genetic elements (MGEs) or DNA close to the remnants of MGEs are found sporadically across different serovars.;The only known effector genes in SPI-2, sseF and sseG, are likely to have conferred an early selective advantage to intracellular bacteria.;several sets of effectors that share high levels of sequence similarity. Examples of paralog effectors include Pathogenicity island-encoded protein B (PipB) and PipB2, which share 33% identity and 67% similarity, SifA and SifB that share 26% identity and 46% similarity, SopE and SopE2, which share 69% similarity, SopD and SopD2 that share 43% identity and 63% similarity. These effector protein paralogs often share structural similarity and/or biochemical activities but demonstrate functional divergence in intracellular localization and/or host protein targets or interaction partners. (sseE) type III secretion system effector SseE [TTSS (SPI-2 encode) (VF0321) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1432 98.462 1.44E-139 sseD VF0321 TTSS (SPI-2 encode) Effector delivery system VFC0086 SPI-2 T3SS effector repertoire varies greatly among different Salmonella serovars.; All serovars seem to have a set of 'core' effectors (SseF, SseG, PipB, SteA, SifA, SteD and PipB2), suggesting that they are critical for virulence in different hosts.; Another group of effectors (SseL, SifB, SopD2, SseJ, SteB, SteC, SlrP, and SseK2) always seem to be present in intestinal serovars but are frequently non-functional in extraintestinal or highly host-adapted serovars, suggesting these effectors contribute to virulence in the intestine, but not always in deeper tissues.;A further group of 'accessory' effectors (SspH2, SseK1, SrfJ, GtgA, GtgE, SseI, GogB, SteE, SseK3, SspH1, SpvB, SpvC, and SpvD) encoded on mobile genetic elements (MGEs) or DNA close to the remnants of MGEs are found sporadically across different serovars.;The only known effector genes in SPI-2, sseF and sseG, are likely to have conferred an early selective advantage to intracellular bacteria.;several sets of effectors that share high levels of sequence similarity. Examples of paralog effectors include Pathogenicity island-encoded protein B (PipB) and PipB2, which share 33% identity and 67% similarity, SifA and SifB that share 26% identity and 46% similarity, SopE and SopE2, which share 69% similarity, SopD and SopD2 that share 43% identity and 63% similarity. These effector protein paralogs often share structural similarity and/or biochemical activities but demonstrate functional divergence in intracellular localization and/or host protein targets or interaction partners. (sseD) type III secretion system hydrophilic translocator, pore protein SseD [TTSS (SPI-2 encode) (VF0321) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1433 95.661 0.0 sseC VF0321 TTSS (SPI-2 encode) Effector delivery system VFC0086 SPI-2 T3SS effector repertoire varies greatly among different Salmonella serovars.; All serovars seem to have a set of 'core' effectors (SseF, SseG, PipB, SteA, SifA, SteD and PipB2), suggesting that they are critical for virulence in different hosts.; Another group of effectors (SseL, SifB, SopD2, SseJ, SteB, SteC, SlrP, and SseK2) always seem to be present in intestinal serovars but are frequently non-functional in extraintestinal or highly host-adapted serovars, suggesting these effectors contribute to virulence in the intestine, but not always in deeper tissues.;A further group of 'accessory' effectors (SspH2, SseK1, SrfJ, GtgA, GtgE, SseI, GogB, SteE, SseK3, SspH1, SpvB, SpvC, and SpvD) encoded on mobile genetic elements (MGEs) or DNA close to the remnants of MGEs are found sporadically across different serovars.;The only known effector genes in SPI-2, sseF and sseG, are likely to have conferred an early selective advantage to intracellular bacteria.;several sets of effectors that share high levels of sequence similarity. Examples of paralog effectors include Pathogenicity island-encoded protein B (PipB) and PipB2, which share 33% identity and 67% similarity, SifA and SifB that share 26% identity and 46% similarity, SopE and SopE2, which share 69% similarity, SopD and SopD2 that share 43% identity and 63% similarity. These effector protein paralogs often share structural similarity and/or biochemical activities but demonstrate functional divergence in intracellular localization and/or host protein targets or interaction partners. (sseC) type III secretion system hydrophilic translocator, pore protein SseC [TTSS (SPI-2 encode) (VF0321) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1434 98.089 8.56E-116 sscA VF0321 TTSS (SPI-2 encode) Effector delivery system VFC0086 SPI-2 T3SS effector repertoire varies greatly among different Salmonella serovars.; All serovars seem to have a set of 'core' effectors (SseF, SseG, PipB, SteA, SifA, SteD and PipB2), suggesting that they are critical for virulence in different hosts.; Another group of effectors (SseL, SifB, SopD2, SseJ, SteB, SteC, SlrP, and SseK2) always seem to be present in intestinal serovars but are frequently non-functional in extraintestinal or highly host-adapted serovars, suggesting these effectors contribute to virulence in the intestine, but not always in deeper tissues.;A further group of 'accessory' effectors (SspH2, SseK1, SrfJ, GtgA, GtgE, SseI, GogB, SteE, SseK3, SspH1, SpvB, SpvC, and SpvD) encoded on mobile genetic elements (MGEs) or DNA close to the remnants of MGEs are found sporadically across different serovars.;The only known effector genes in SPI-2, sseF and sseG, are likely to have conferred an early selective advantage to intracellular bacteria.;several sets of effectors that share high levels of sequence similarity. Examples of paralog effectors include Pathogenicity island-encoded protein B (PipB) and PipB2, which share 33% identity and 67% similarity, SifA and SifB that share 26% identity and 46% similarity, SopE and SopE2, which share 69% similarity, SopD and SopD2 that share 43% identity and 63% similarity. These effector protein paralogs often share structural similarity and/or biochemical activities but demonstrate functional divergence in intracellular localization and/or host protein targets or interaction partners. (sscA) chaperone for sseC [TTSS (SPI-2 encode) (VF0321) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1435 98.98 1.99E-143 sseB VF0321 TTSS (SPI-2 encode) Effector delivery system VFC0086 SPI-2 T3SS effector repertoire varies greatly among different Salmonella serovars.; All serovars seem to have a set of 'core' effectors (SseF, SseG, PipB, SteA, SifA, SteD and PipB2), suggesting that they are critical for virulence in different hosts.; Another group of effectors (SseL, SifB, SopD2, SseJ, SteB, SteC, SlrP, and SseK2) always seem to be present in intestinal serovars but are frequently non-functional in extraintestinal or highly host-adapted serovars, suggesting these effectors contribute to virulence in the intestine, but not always in deeper tissues.;A further group of 'accessory' effectors (SspH2, SseK1, SrfJ, GtgA, GtgE, SseI, GogB, SteE, SseK3, SspH1, SpvB, SpvC, and SpvD) encoded on mobile genetic elements (MGEs) or DNA close to the remnants of MGEs are found sporadically across different serovars.;The only known effector genes in SPI-2, sseF and sseG, are likely to have conferred an early selective advantage to intracellular bacteria.;several sets of effectors that share high levels of sequence similarity. Examples of paralog effectors include Pathogenicity island-encoded protein B (PipB) and PipB2, which share 33% identity and 67% similarity, SifA and SifB that share 26% identity and 46% similarity, SopE and SopE2, which share 69% similarity, SopD and SopD2 that share 43% identity and 63% similarity. These effector protein paralogs often share structural similarity and/or biochemical activities but demonstrate functional divergence in intracellular localization and/or host protein targets or interaction partners. (sseB) type III secretion system effector SseB [TTSS (SPI-2 encode) (VF0321) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1436 99.065 1.98E-75 sseA VF0321 TTSS (SPI-2 encode) Effector delivery system VFC0086 SPI-2 T3SS effector repertoire varies greatly among different Salmonella serovars.; All serovars seem to have a set of 'core' effectors (SseF, SseG, PipB, SteA, SifA, SteD and PipB2), suggesting that they are critical for virulence in different hosts.; Another group of effectors (SseL, SifB, SopD2, SseJ, SteB, SteC, SlrP, and SseK2) always seem to be present in intestinal serovars but are frequently non-functional in extraintestinal or highly host-adapted serovars, suggesting these effectors contribute to virulence in the intestine, but not always in deeper tissues.;A further group of 'accessory' effectors (SspH2, SseK1, SrfJ, GtgA, GtgE, SseI, GogB, SteE, SseK3, SspH1, SpvB, SpvC, and SpvD) encoded on mobile genetic elements (MGEs) or DNA close to the remnants of MGEs are found sporadically across different serovars.;The only known effector genes in SPI-2, sseF and sseG, are likely to have conferred an early selective advantage to intracellular bacteria.;several sets of effectors that share high levels of sequence similarity. Examples of paralog effectors include Pathogenicity island-encoded protein B (PipB) and PipB2, which share 33% identity and 67% similarity, SifA and SifB that share 26% identity and 46% similarity, SopE and SopE2, which share 69% similarity, SopD and SopD2 that share 43% identity and 63% similarity. These effector protein paralogs often share structural similarity and/or biochemical activities but demonstrate functional divergence in intracellular localization and/or host protein targets or interaction partners. (sseA) chaperone for sseB and sseD [TTSS (SPI-2 encode) (VF0321) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1437 98.75 6.07E-53 ssaE VF0321 TTSS (SPI-2 encode) Effector delivery system VFC0086 SPI-2 T3SS effector repertoire varies greatly among different Salmonella serovars.; All serovars seem to have a set of 'core' effectors (SseF, SseG, PipB, SteA, SifA, SteD and PipB2), suggesting that they are critical for virulence in different hosts.; Another group of effectors (SseL, SifB, SopD2, SseJ, SteB, SteC, SlrP, and SseK2) always seem to be present in intestinal serovars but are frequently non-functional in extraintestinal or highly host-adapted serovars, suggesting these effectors contribute to virulence in the intestine, but not always in deeper tissues.;A further group of 'accessory' effectors (SspH2, SseK1, SrfJ, GtgA, GtgE, SseI, GogB, SteE, SseK3, SspH1, SpvB, SpvC, and SpvD) encoded on mobile genetic elements (MGEs) or DNA close to the remnants of MGEs are found sporadically across different serovars.;The only known effector genes in SPI-2, sseF and sseG, are likely to have conferred an early selective advantage to intracellular bacteria.;several sets of effectors that share high levels of sequence similarity. Examples of paralog effectors include Pathogenicity island-encoded protein B (PipB) and PipB2, which share 33% identity and 67% similarity, SifA and SifB that share 26% identity and 46% similarity, SopE and SopE2, which share 69% similarity, SopD and SopD2 that share 43% identity and 63% similarity. These effector protein paralogs often share structural similarity and/or biochemical activities but demonstrate functional divergence in intracellular localization and/or host protein targets or interaction partners. (ssaE) chaperone for sseB [TTSS (SPI-2 encode) (VF0321) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1438 98.759 0.0 ssaD VF0321 TTSS (SPI-2 encode) Effector delivery system VFC0086 SPI-2 T3SS effector repertoire varies greatly among different Salmonella serovars.; All serovars seem to have a set of 'core' effectors (SseF, SseG, PipB, SteA, SifA, SteD and PipB2), suggesting that they are critical for virulence in different hosts.; Another group of effectors (SseL, SifB, SopD2, SseJ, SteB, SteC, SlrP, and SseK2) always seem to be present in intestinal serovars but are frequently non-functional in extraintestinal or highly host-adapted serovars, suggesting these effectors contribute to virulence in the intestine, but not always in deeper tissues.;A further group of 'accessory' effectors (SspH2, SseK1, SrfJ, GtgA, GtgE, SseI, GogB, SteE, SseK3, SspH1, SpvB, SpvC, and SpvD) encoded on mobile genetic elements (MGEs) or DNA close to the remnants of MGEs are found sporadically across different serovars.;The only known effector genes in SPI-2, sseF and sseG, are likely to have conferred an early selective advantage to intracellular bacteria.;several sets of effectors that share high levels of sequence similarity. Examples of paralog effectors include Pathogenicity island-encoded protein B (PipB) and PipB2, which share 33% identity and 67% similarity, SifA and SifB that share 26% identity and 46% similarity, SopE and SopE2, which share 69% similarity, SopD and SopD2 that share 43% identity and 63% similarity. These effector protein paralogs often share structural similarity and/or biochemical activities but demonstrate functional divergence in intracellular localization and/or host protein targets or interaction partners. (ssaD) type III secretion system outer MS ring protein SsaD [TTSS (SPI-2 encode) (VF0321) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1439 99.598 0.0 ssaC VF0321 TTSS (SPI-2 encode) Effector delivery system VFC0086 SPI-2 T3SS effector repertoire varies greatly among different Salmonella serovars.; All serovars seem to have a set of 'core' effectors (SseF, SseG, PipB, SteA, SifA, SteD and PipB2), suggesting that they are critical for virulence in different hosts.; Another group of effectors (SseL, SifB, SopD2, SseJ, SteB, SteC, SlrP, and SseK2) always seem to be present in intestinal serovars but are frequently non-functional in extraintestinal or highly host-adapted serovars, suggesting these effectors contribute to virulence in the intestine, but not always in deeper tissues.;A further group of 'accessory' effectors (SspH2, SseK1, SrfJ, GtgA, GtgE, SseI, GogB, SteE, SseK3, SspH1, SpvB, SpvC, and SpvD) encoded on mobile genetic elements (MGEs) or DNA close to the remnants of MGEs are found sporadically across different serovars.;The only known effector genes in SPI-2, sseF and sseG, are likely to have conferred an early selective advantage to intracellular bacteria.;several sets of effectors that share high levels of sequence similarity. Examples of paralog effectors include Pathogenicity island-encoded protein B (PipB) and PipB2, which share 33% identity and 67% similarity, SifA and SifB that share 26% identity and 46% similarity, SopE and SopE2, which share 69% similarity, SopD and SopD2 that share 43% identity and 63% similarity. These effector protein paralogs often share structural similarity and/or biochemical activities but demonstrate functional divergence in intracellular localization and/or host protein targets or interaction partners. (ssaC) type III secretion system secretin SsaC [TTSS (SPI-2 encode) (VF0321) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1440 99.213 1.66E-92 spiC/ssaB VF0321 TTSS (SPI-2 encode) Effector delivery system VFC0086 SPI-2 T3SS effector repertoire varies greatly among different Salmonella serovars.; All serovars seem to have a set of 'core' effectors (SseF, SseG, PipB, SteA, SifA, SteD and PipB2), suggesting that they are critical for virulence in different hosts.; Another group of effectors (SseL, SifB, SopD2, SseJ, SteB, SteC, SlrP, and SseK2) always seem to be present in intestinal serovars but are frequently non-functional in extraintestinal or highly host-adapted serovars, suggesting these effectors contribute to virulence in the intestine, but not always in deeper tissues.;A further group of 'accessory' effectors (SspH2, SseK1, SrfJ, GtgA, GtgE, SseI, GogB, SteE, SseK3, SspH1, SpvB, SpvC, and SpvD) encoded on mobile genetic elements (MGEs) or DNA close to the remnants of MGEs are found sporadically across different serovars.;The only known effector genes in SPI-2, sseF and sseG, are likely to have conferred an early selective advantage to intracellular bacteria.;several sets of effectors that share high levels of sequence similarity. Examples of paralog effectors include Pathogenicity island-encoded protein B (PipB) and PipB2, which share 33% identity and 67% similarity, SifA and SifB that share 26% identity and 46% similarity, SopE and SopE2, which share 69% similarity, SopD and SopD2 that share 43% identity and 63% similarity. These effector protein paralogs often share structural similarity and/or biochemical activities but demonstrate functional divergence in intracellular localization and/or host protein targets or interaction partners. (spiC/ssaB) Salmonella pathogenicity island 2 protein C (SpiC); Type III secretion system apparatus protein B (SsaB) [TTSS (SPI-2 encode) (VF0321) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1441 98.913 0.0 ssrA VF0321 TTSS (SPI-2 encode) Effector delivery system VFC0086 SPI-2 T3SS effector repertoire varies greatly among different Salmonella serovars.; All serovars seem to have a set of 'core' effectors (SseF, SseG, PipB, SteA, SifA, SteD and PipB2), suggesting that they are critical for virulence in different hosts.; Another group of effectors (SseL, SifB, SopD2, SseJ, SteB, SteC, SlrP, and SseK2) always seem to be present in intestinal serovars but are frequently non-functional in extraintestinal or highly host-adapted serovars, suggesting these effectors contribute to virulence in the intestine, but not always in deeper tissues.;A further group of 'accessory' effectors (SspH2, SseK1, SrfJ, GtgA, GtgE, SseI, GogB, SteE, SseK3, SspH1, SpvB, SpvC, and SpvD) encoded on mobile genetic elements (MGEs) or DNA close to the remnants of MGEs are found sporadically across different serovars.;The only known effector genes in SPI-2, sseF and sseG, are likely to have conferred an early selective advantage to intracellular bacteria.;several sets of effectors that share high levels of sequence similarity. Examples of paralog effectors include Pathogenicity island-encoded protein B (PipB) and PipB2, which share 33% identity and 67% similarity, SifA and SifB that share 26% identity and 46% similarity, SopE and SopE2, which share 69% similarity, SopD and SopD2 that share 43% identity and 63% similarity. These effector protein paralogs often share structural similarity and/or biochemical activities but demonstrate functional divergence in intracellular localization and/or host protein targets or interaction partners. (ssrA) hybrid sensor histidine kinase/response regulator [TTSS (SPI-2 encode) (VF0321) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1442 99.528 3.35E-158 ssrB VF0321 TTSS (SPI-2 encode) Effector delivery system VFC0086 SPI-2 T3SS effector repertoire varies greatly among different Salmonella serovars.; All serovars seem to have a set of 'core' effectors (SseF, SseG, PipB, SteA, SifA, SteD and PipB2), suggesting that they are critical for virulence in different hosts.; Another group of effectors (SseL, SifB, SopD2, SseJ, SteB, SteC, SlrP, and SseK2) always seem to be present in intestinal serovars but are frequently non-functional in extraintestinal or highly host-adapted serovars, suggesting these effectors contribute to virulence in the intestine, but not always in deeper tissues.;A further group of 'accessory' effectors (SspH2, SseK1, SrfJ, GtgA, GtgE, SseI, GogB, SteE, SseK3, SspH1, SpvB, SpvC, and SpvD) encoded on mobile genetic elements (MGEs) or DNA close to the remnants of MGEs are found sporadically across different serovars.;The only known effector genes in SPI-2, sseF and sseG, are likely to have conferred an early selective advantage to intracellular bacteria.;several sets of effectors that share high levels of sequence similarity. Examples of paralog effectors include Pathogenicity island-encoded protein B (PipB) and PipB2, which share 33% identity and 67% similarity, SifA and SifB that share 26% identity and 46% similarity, SopE and SopE2, which share 69% similarity, SopD and SopD2 that share 43% identity and 63% similarity. These effector protein paralogs often share structural similarity and/or biochemical activities but demonstrate functional divergence in intracellular localization and/or host protein targets or interaction partners. (ssrB) DNA-binding response regulator [TTSS (SPI-2 encode) (VF0321) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1577 99.257 0.0 cdtB VF0407 Typhoid toxin Exotoxin VFC0235 Classic cytolethal distending toxins (CDTs) are three component AB toxins, composed of CdtA, CdtB and CdtC. CdtA and CdtC mediate target cell binding and membrane translocation of CdtB, which then induces DNA damage, most probably through its nuclease activity; In the case of S. typhi, however, genes encoding CdtA and CdtC are absent. CdtB from S. typhi is produced with the pertussis-like toxins PltA and PltB only inside the host cell and is then secreted from the infected Cell in a PltA/B-Dependent manner and acts then as a classical CDT from outside;typhoid toxin seemed to have evolved from the combination of the activities of two exotoxin ancestors, CDT and pertussis toxins; The typhoid toxin is an atypical AB toxin encoded on SPI-11; The toxin is expressed exclusively when S. Typhi is intracellualr and localized within the Salmonella containing vacuole (SCV); Homologues are found in S. Paratyphi A and several NTS serovars, but are absent from S. Typhimurium and S. Enteritidis; The typhoid toxin is secreted within vesicles originating from the SCV and released into the extracellular space (cdtB) cytolethal distending toxin B [Typhoid toxin (VF0407) - Exotoxin (VFC0235)] [Salmonella enterica subsp. enterica serovar Typhi str. CT18] Salmonella enterica (serovar typhi)
CP011967.1_1580 99.587 0.0 pltA VF0407 Typhoid toxin Exotoxin VFC0235 Classic cytolethal distending toxins (CDTs) are three component AB toxins, composed of CdtA, CdtB and CdtC. CdtA and CdtC mediate target cell binding and membrane translocation of CdtB, which then induces DNA damage, most probably through its nuclease activity; In the case of S. typhi, however, genes encoding CdtA and CdtC are absent. CdtB from S. typhi is produced with the pertussis-like toxins PltA and PltB only inside the host cell and is then secreted from the infected Cell in a PltA/B-Dependent manner and acts then as a classical CDT from outside;typhoid toxin seemed to have evolved from the combination of the activities of two exotoxin ancestors, CDT and pertussis toxins; The typhoid toxin is an atypical AB toxin encoded on SPI-11; The toxin is expressed exclusively when S. Typhi is intracellualr and localized within the Salmonella containing vacuole (SCV); Homologues are found in S. Paratyphi A and several NTS serovars, but are absent from S. Typhimurium and S. Enteritidis; The typhoid toxin is secreted within vesicles originating from the SCV and released into the extracellular space (pltA) typhoid-like toxin S-CDT ADP-ribosylating subunit PltA [Typhoid toxin (VF0407) - Exotoxin (VFC0235)] [Salmonella enterica subsp. enterica serovar Typhi str. CT18] Salmonella enterica (serovar typhi)
CP011967.1_1581 97.81 2.58E-100 pltB VF0407 Typhoid toxin Exotoxin VFC0235 Classic cytolethal distending toxins (CDTs) are three component AB toxins, composed of CdtA, CdtB and CdtC. CdtA and CdtC mediate target cell binding and membrane translocation of CdtB, which then induces DNA damage, most probably through its nuclease activity; In the case of S. typhi, however, genes encoding CdtA and CdtC are absent. CdtB from S. typhi is produced with the pertussis-like toxins PltA and PltB only inside the host cell and is then secreted from the infected Cell in a PltA/B-Dependent manner and acts then as a classical CDT from outside;typhoid toxin seemed to have evolved from the combination of the activities of two exotoxin ancestors, CDT and pertussis toxins; The typhoid toxin is an atypical AB toxin encoded on SPI-11; The toxin is expressed exclusively when S. Typhi is intracellualr and localized within the Salmonella containing vacuole (SCV); Homologues are found in S. Paratyphi A and several NTS serovars, but are absent from S. Typhimurium and S. Enteritidis; The typhoid toxin is secreted within vesicles originating from the SCV and released into the extracellular space (pltB) typhoid-like toxin S-CDT binding subunit PltB [Typhoid toxin (VF0407) - Exotoxin (VFC0235)] [Salmonella enterica subsp. enterica serovar Typhi str. CT18] Salmonella enterica (serovar typhi)
CP011967.1_1591 100.0 1.34E-166 phoP VF0111 PhoPQ Regulation VFC0301 (phoP) response regulator in two-component regulatory system with PhoQ [PhoPQ (VF0111) - Regulation (VFC0301)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1592 100.0 0.0 phoQ VF0111 PhoPQ Regulation VFC0301 (phoQ) sensor protein PhoQ [PhoPQ (VF0111) - Regulation (VFC0301)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1598 93.75 0.0 sifA VF0947 TTSS-2 secreted effectors Effector delivery system VFC0086 (sifA) type III secretion system effector SifA (Salmonella induced filament protein A) [TTSS-2 secreted effectors (VF0947) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1628 61.538 1.93E-27 acpXL VF0367 LPS Immune modulation VFC0258 Brucella possesses a non-classical LPS as compared with the so-called classical LPS from enterobacteria such as Escherichia coli. B. abortus lipid A possesses a diaminoglucose backbone (rather than glucosamine), and acyl groups are longer (C28 rather than C12 and C16) and are only linked to the core by amide bounds (rather than ester and amide bonds).; In contrast to enterobacterial LPSs, Brucella LPS is several-hundred-times less active and toxic than E. coli LPS.; this is an evolutionary adaptation to an intracellular lifestyle, low endotoxic activity is shared by other intracellular pathogens such as Bartonella and Legionella. (acpXL) acyl carrier protein [LPS (VF0367) - Immune modulation (VFC0258)] [Brucella melitensis bv. 1 str. 16M] Brucella melitensis
CP011967.1_1629 77.459 1.72E-139 flmH VF0473 Polar flagella Motility VFC0204 Types of bacterial movement: swimming, swarming, gliding, twitching and sliding. Only swimming and swarming are correlated with the presence of flagella. Swimming is an individual endeavour, while swarming is the movement of a group of bacteria; constitutively expressed for motility in liquid environments (flmH) short chain dehydrogenase/reductase family oxidoreductase [Polar flagella (VF0473) - Motility (VFC0204)] [Aeromonas hydrophila ML09-119] Aeromonas hydrophila
CP011967.1_1640 61.146 2.38E-137 flgJ VF0394 Flagella Motility VFC0204 (flgJ) <beta>-N-acetylglucosaminidase [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] Yersinia enterocolitica
CP011967.1_1641 79.05 0.0 flgI VF0394 Flagella Motility VFC0204 (flgI) flagellar P-ring protein precursor FlgI [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] Yersinia enterocolitica
CP011967.1_1642 82.16 4.37E-122 flgH VF0394 Flagella Motility VFC0204 (flgH) flagellar L-ring protein precursor FlgH [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] Yersinia enterocolitica
CP011967.1_1643 87.308 5.49E-170 flgG VF0394 Flagella Motility VFC0204 (flgG) flagellar basal-body rod protein FlgG [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] Yersinia enterocolitica
CP011967.1_1644 69.721 6.0E-126 flgF VF0394 Flagella Motility VFC0204 (flgF) flagellar basal-body rod protein FlgF [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] Yersinia enterocolitica
CP011967.1_1645 63.183 1.68E-180 flgE VF0394 Flagella Motility VFC0204 (flgE) flagellar hook protein FlgE [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] Yersinia enterocolitica
CP011967.1_1646 71.287 9.94E-99 flgD VF0394 Flagella Motility VFC0204 (flgD) flagellar basal-body rod modification protein FlgD [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] Yersinia enterocolitica
CP011967.1_1647 81.343 1.06E-80 flgC VF0394 Flagella Motility VFC0204 (flgC) flagellar basal-body rod protein FlgC [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] Yersinia enterocolitica
CP011967.1_1648 76.642 3.41E-76 flgB VF0394 Flagella Motility VFC0204 (flgB) flagellar basal-body rod protein FlgB [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] Yersinia enterocolitica
CP011967.1_1676 99.074 6.2E-74 csgC VF0103 Agf Adherence VFC0001 Homology to csg of E.coli; nucleator-dependent assembly pathway (csgC) curli assembly protein CsgC [Agf (VF0103) - Adherence (VFC0001)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1677 100.0 3.01E-106 csgA VF0103 Agf Adherence VFC0001 Homology to csg of E.coli; nucleator-dependent assembly pathway (csgA) curlin major subunit CsgA [Agf (VF0103) - Adherence (VFC0001)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1678 100.0 2.17E-108 csgB VF0103 Agf Adherence VFC0001 Homology to csg of E.coli; nucleator-dependent assembly pathway (csgB) minor curlin subunit precursor, curli nucleator protein CsgB [Agf (VF0103) - Adherence (VFC0001)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1679 99.537 8.37E-163 csgD VF0103 Agf Adherence VFC0001 Homology to csg of E.coli; nucleator-dependent assembly pathway (csgD) DNA-binding transcriptional regulator CsgD [Agf (VF0103) - Adherence (VFC0001)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1680 100.0 1.59E-96 csgE VF0103 Agf Adherence VFC0001 Homology to csg of E.coli; nucleator-dependent assembly pathway (csgE) curli production assembly/transport protein CsgE [Agf (VF0103) - Adherence (VFC0001)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1681 100.0 9.16E-83 csgF VF0103 Agf Adherence VFC0001 Homology to csg of E.coli; nucleator-dependent assembly pathway (csgF) curli production assembly/transport protein CsgF [Agf (VF0103) - Adherence (VFC0001)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1682 100.0 0.0 csgG VF0103 Agf Adherence VFC0001 Homology to csg of E.coli; nucleator-dependent assembly pathway (csgG) curli production assembly/transport protein CsgG [Agf (VF0103) - Adherence (VFC0001)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1732 98.217 0.0 sopB/sigD VF0949 TTSS-1 secreted effectors Effector delivery system VFC0086 (sopB/sigD) type III secretion system effector SopB, phosphoinositide phosphatase [TTSS-1 secreted effectors (VF0949) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1734 97.938 0.0 pipB VF0947 TTSS-2 secreted effectors Effector delivery system VFC0086 (pipB) type III secretion system effector PipB [TTSS-2 secreted effectors (VF0947) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1752 92.857 0.0 ompA VF0236 OmpA Invasion VFC0083 Major outer membrane protein in E. coli, homologous to Neisseria Opa proteins which have been shown to be involved in invasion of eukaryotic cells (ompA) outer membrane protein A [OmpA (VF0236) - Invasion (VFC0083)] [Escherichia coli O18:K1:H7 str. RS218] Escherichia coli (NMEC)
CP011967.1_1781 69.076 6.56E-124 nueA VF0473 Polar flagella Motility VFC0204 Types of bacterial movement: swimming, swarming, gliding, twitching and sliding. Only swimming and swarming are correlated with the presence of flagella. Swimming is an individual endeavour, while swarming is the movement of a group of bacteria; constitutively expressed for motility in liquid environments (nueA) NeuA protein [Polar flagella (VF0473) - Motility (VFC0204)] [Aeromonas hydrophila ML09-119] Aeromonas hydrophila
CP011967.1_1785 66.09 0.0 msbA VF0044 LOS Immune modulation VFC0258 Lic1A (phosphorylcholine (ChoP) kinase) 5'-CAAT-3' within the 5'-end of its coding sequence; lic2A, also referred to as lexA, variation in the number of 5'-CAAT-3' repeats has been shown to correlate directly with phase variation of the Gal-alpha(1-4)beta-Gal LPS structure; But lgtC (glycosyltransferase), another phase-variable gene, ultimately dictates whether this structure is synthesized. lic3A encode a sialyl transferase which directs the substitution of LPS with sialic acid. (msbA) lipid transporter ATP-binding/permease [LOS (VF0044) - Immune modulation (VFC0258)] [Haemophilus influenzae Rd KW20] Haemophilus influenzae
CP011967.1_1798 89.954 5.58E-145 sopD2 VF0947 TTSS-2 secreted effectors Effector delivery system VFC0086 (sopD2) type III secretion system effector SopD2 [TTSS-2 secreted effectors (VF0947) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1925 89.256 1.16E-152 slrP VF0948 TTSS effectors secreted via both systems Effector delivery system VFC0086 (slrP) type III secretion system effector SlrP (Salmonella leucine-rich repeat protein),novel E3 ubiquitin ligase [TTSS effectors secreted via both systems (VF0948) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1926 94.04 0.0 slrP VF0948 TTSS effectors secreted via both systems Effector delivery system VFC0086 (slrP) type III secretion system effector SlrP (Salmonella leucine-rich repeat protein),novel E3 ubiquitin ligase [TTSS effectors secreted via both systems (VF0948) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_1991 69.333 0.0 KP1_RS17225 VF0561 LPS Immune modulation VFC0258 In K. pneumoniae there are nine main O-serotypes. Three of these, O1, O2, and O3, are responsible for almost 80% of all Klebsiella infections.; Compared with other Enterobacteriaceae, such as Escherichia coli 161 defined O serotypes and Shigella flexneri at least 47 O serotypes, Klebsiella has a surprisingly low number of reported O serotypes which promises a more viable alternative for vaccine development compared with K-antigen-based vaccines; The O-antigen biosynthesis enzymes are encoded on the rfb locus. (KP1_RS17225) glycosyltransferase family 4 protein [LPS (VF0561) - Immune modulation (VFC0258)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] Klebsiella pneumoniae
CP011967.1_1993 77.023 0.0 rfbD VF0561 LPS Immune modulation VFC0258 In K. pneumoniae there are nine main O-serotypes. Three of these, O1, O2, and O3, are responsible for almost 80% of all Klebsiella infections.; Compared with other Enterobacteriaceae, such as Escherichia coli 161 defined O serotypes and Shigella flexneri at least 47 O serotypes, Klebsiella has a surprisingly low number of reported O serotypes which promises a more viable alternative for vaccine development compared with K-antigen-based vaccines; The O-antigen biosynthesis enzymes are encoded on the rfb locus. (rfbD) UDP-galactopyranose mutase [LPS (VF0561) - Immune modulation (VFC0258)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] Klebsiella pneumoniae
CP011967.1_1995 62.703 9.66E-80 fimB VF0566 Type I fimbriae Adherence VFC0001 Type I fimbriae are expressed in 90% of both clinical and environmental K. pneumoniae isolates as well as almost all members of the Enterobacteriaceae.; Type I fimbriae are filamentous, membrane-bound, adhesive structures composed primarily of FimA subunits, with the FimH subunit on the tip. (fimB) tyrosine recombinase [Type I fimbriae (VF0566) - Adherence (VFC0001)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] Klebsiella pneumoniae
CP011967.1_2018 100.0 4.99E-111 fur VF0113 Fur Regulation VFC0301 (fur) ferric iron uptake transcriptional regulator [Fur (VF0113) - Regulation (VFC0301)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2101 89.113 7.02E-164 entA VF0228 Enterobactin Nutritional/Metabolic factor VFC0272 An extremely effective iron chelator, with a formation constant for the iron complex of 1049. Fe3+ is coordinated by six catechol oxygens to form a metal chelate with a net negative charge of three (entA) 2,3-dihydro-2,3-dihydroxybenzoate dehydrogenase EntA [Enterobactin (VF0228) - Nutritional/Metabolic factor (VFC0272)] [Escherichia coli CFT073] Escherichia coli (UPEC)
CP011967.1_2102 88.07 0.0 entB VF0228 Enterobactin Nutritional/Metabolic factor VFC0272 An extremely effective iron chelator, with a formation constant for the iron complex of 1049. Fe3+ is coordinated by six catechol oxygens to form a metal chelate with a net negative charge of three (entB) isochorismatase [Enterobactin (VF0228) - Nutritional/Metabolic factor (VFC0272)] [Escherichia coli CFT073] Escherichia coli (UPEC)
CP011967.1_2103 86.517 0.0 entE VF0228 Enterobactin Nutritional/Metabolic factor VFC0272 An extremely effective iron chelator, with a formation constant for the iron complex of 1049. Fe3+ is coordinated by six catechol oxygens to form a metal chelate with a net negative charge of three (entE) 2,3-dihydroxybenzoate-AMP ligase component of enterobactin synthase multienzyme complex [Enterobactin (VF0228) - Nutritional/Metabolic factor (VFC0272)] [Escherichia coli CFT073] Escherichia coli (UPEC)
CP011967.1_2104 84.655 0.0 entC VF0228 Enterobactin Nutritional/Metabolic factor VFC0272 An extremely effective iron chelator, with a formation constant for the iron complex of 1049. Fe3+ is coordinated by six catechol oxygens to form a metal chelate with a net negative charge of three (entC) isochorismate synthase 1 [Enterobactin (VF0228) - Nutritional/Metabolic factor (VFC0272)] [Escherichia coli CFT073] Escherichia coli (UPEC)
CP011967.1_2105 78.931 0.0 fepB VF0228 Enterobactin Nutritional/Metabolic factor VFC0272 An extremely effective iron chelator, with a formation constant for the iron complex of 1049. Fe3+ is coordinated by six catechol oxygens to form a metal chelate with a net negative charge of three (fepB) ferrienterobactin ABC transporter periplasmic binding protein [Enterobactin (VF0228) - Nutritional/Metabolic factor (VFC0272)] [Escherichia coli CFT073] Escherichia coli (UPEC)
CP011967.1_2106 90.22 0.0 entS VF0228 Enterobactin Nutritional/Metabolic factor VFC0272 An extremely effective iron chelator, with a formation constant for the iron complex of 1049. Fe3+ is coordinated by six catechol oxygens to form a metal chelate with a net negative charge of three (entS) enterobactin exporter, iron-regulated [Enterobactin (VF0228) - Nutritional/Metabolic factor (VFC0272)] [Escherichia coli CFT073] Escherichia coli (UPEC)
CP011967.1_2107 84.478 0.0 fepD VF0562 Ent Nutritional/Metabolic factor VFC0272 Various iron acquisition systems in Klebsiella are needed to overcome host defenses in different anatomical compartments. (fepD) iron-enterobactin transporter membrane protein [Ent (VF0562) - Nutritional/Metabolic factor (VFC0272)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] Klebsiella pneumoniae
CP011967.1_2108 86.93 0.0 fepG VF0228 Enterobactin Nutritional/Metabolic factor VFC0272 An extremely effective iron chelator, with a formation constant for the iron complex of 1049. Fe3+ is coordinated by six catechol oxygens to form a metal chelate with a net negative charge of three (fepG) iron-enterobactin ABC transporter permease [Enterobactin (VF0228) - Nutritional/Metabolic factor (VFC0272)] [Escherichia coli CFT073] Escherichia coli (UPEC)
CP011967.1_2109 92.776 0.0 fepC VF0228 Enterobactin Nutritional/Metabolic factor VFC0272 An extremely effective iron chelator, with a formation constant for the iron complex of 1049. Fe3+ is coordinated by six catechol oxygens to form a metal chelate with a net negative charge of three (fepC) ferrienterobactin ABC transporter ATPase [Enterobactin (VF0228) - Nutritional/Metabolic factor (VFC0272)] [Escherichia coli CFT073] Escherichia coli (UPEC)
CP011967.1_2110 73.19 0.0 fepE VF0228 Enterobactin Nutritional/Metabolic factor VFC0272 An extremely effective iron chelator, with a formation constant for the iron complex of 1049. Fe3+ is coordinated by six catechol oxygens to form a metal chelate with a net negative charge of three (fepE) LPS O-antigen length regulator [Enterobactin (VF0228) - Nutritional/Metabolic factor (VFC0272)] [Escherichia coli CFT073] Escherichia coli (UPEC)
CP011967.1_2111 78.98 0.0 entF VF0228 Enterobactin Nutritional/Metabolic factor VFC0272 An extremely effective iron chelator, with a formation constant for the iron complex of 1049. Fe3+ is coordinated by six catechol oxygens to form a metal chelate with a net negative charge of three (entF) enterobactin synthase multienzyme complex component, ATP-dependent [Enterobactin (VF0228) - Nutritional/Metabolic factor (VFC0272)] [Escherichia coli CFT073] Escherichia coli (UPEC)
CP011967.1_2113 73.869 0.0 fes VF0228 Enterobactin Nutritional/Metabolic factor VFC0272 An extremely effective iron chelator, with a formation constant for the iron complex of 1049. Fe3+ is coordinated by six catechol oxygens to form a metal chelate with a net negative charge of three (fes) enterobactin/ferric enterobactin esterase [Enterobactin (VF0228) - Nutritional/Metabolic factor (VFC0272)] [Escherichia coli CFT073] Escherichia coli (UPEC)
CP011967.1_2114 82.252 0.0 fepA VF0228 Enterobactin Nutritional/Metabolic factor VFC0272 An extremely effective iron chelator, with a formation constant for the iron complex of 1049. Fe3+ is coordinated by six catechol oxygens to form a metal chelate with a net negative charge of three (fepA) ferrienterobactin outer membrane transporter [Enterobactin (VF0228) - Nutritional/Metabolic factor (VFC0272)] [Escherichia coli CFT073] Escherichia coli (UPEC)
CP011967.1_2131 79.167 2.31E-70 gtrA VF0124 LPS Immune modulation VFC0258 Composed of the O-antigen, core polysaccharides and lipid A; the genes involved in the biosynthesis of the basic O-antigen are located in the rfb/rfc loci; O-antigen modification is associated with temperate bacteriophages. Four different serotype-converting phages have been found: SfII, Sf6, SfV and SfX, which are involved in conversion of a serotype Y stain to serotypes 2a, 3b, 5a and X, respectively (gtrA) bactoprenol-linked glucose translocase/flippase [LPS (VF0124) - Immune modulation (VFC0258)] [Shigella flexneri 2a str. 301] Shigella flexneri
CP011967.1_2132 88.235 0.0 gtrB VF0124 LPS Immune modulation VFC0258 Composed of the O-antigen, core polysaccharides and lipid A; the genes involved in the biosynthesis of the basic O-antigen are located in the rfb/rfc loci; O-antigen modification is associated with temperate bacteriophages. Four different serotype-converting phages have been found: SfII, Sf6, SfV and SfX, which are involved in conversion of a serotype Y stain to serotypes 2a, 3b, 5a and X, respectively (gtrB) bactoprenol glucosyl transferase [LPS (VF0124) - Immune modulation (VFC0258)] [Shigella flexneri 2a str. 301] Shigella flexneri
CP011967.1_2137 98.99 2.43E-148 fimW VF0102 Type 1 fimbriae Adherence VFC0001 Chaperone-usher assembly pathway (fimW) helix-turn-helix transcriptional regulator [Type 1 fimbriae (VF0102) - Adherence (VFC0001)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2138 97.083 1.99E-173 fimY VF0102 Type 1 fimbriae Adherence VFC0001 Chaperone-usher assembly pathway (fimY) fimbriae Y protein [Type 1 fimbriae (VF0102) - Adherence (VFC0001)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2139 100.0 1.07E-155 fimZ VF0102 Type 1 fimbriae Adherence VFC0001 Chaperone-usher assembly pathway (fimZ) DNA-binding response regulator [Type 1 fimbriae (VF0102) - Adherence (VFC0001)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2140 99.419 7.25E-126 fimF VF0102 Type 1 fimbriae Adherence VFC0001 Chaperone-usher assembly pathway (fimF) type I fimbriae adaptor protein FimF [Type 1 fimbriae (VF0102) - Adherence (VFC0001)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2141 99.403 0.0 fimH VF0102 Type 1 fimbriae Adherence VFC0001 Chaperone-usher assembly pathway (fimH) type I fimbriae minor fimbrial subunit FimH, adhesin [Type 1 fimbriae (VF0102) - Adherence (VFC0001)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2142 98.046 0.0 fimD VF0102 Type 1 fimbriae Adherence VFC0001 Chaperone-usher assembly pathway (fimD) usher protein FimD [Type 1 fimbriae (VF0102) - Adherence (VFC0001)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2143 97.826 1.31E-167 fimC VF0102 Type 1 fimbriae Adherence VFC0001 Chaperone-usher assembly pathway (fimC) chaperone protein FimC [Type 1 fimbriae (VF0102) - Adherence (VFC0001)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2144 98.87 3.63E-130 fimI VF0102 Type 1 fimbriae Adherence VFC0001 Chaperone-usher assembly pathway (fimI) fimbrial protein internal segment [Type 1 fimbriae (VF0102) - Adherence (VFC0001)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2145 97.838 5.3E-131 fimA VF0102 Type 1 fimbriae Adherence VFC0001 Chaperone-usher assembly pathway (fimA) type-1 fimbrial protein subunit A [Type 1 fimbriae (VF0102) - Adherence (VFC0001)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2159 81.948 0.0 allD VF0572 Allantion utilization Nutritional/Metabolic factor VFC0272 An allantoin utilization operon has been associated with hypervirulent K. pneumoniae strains that cause pyogenic liver abscesses. (allD) ureidoglycolate dehydrogenase [Allantion utilization (VF0572) - Nutritional/Metabolic factor (VFC0272)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] Klebsiella pneumoniae
CP011967.1_2160 79.951 0.0 allC VF0572 Allantion utilization Nutritional/Metabolic factor VFC0272 An allantoin utilization operon has been associated with hypervirulent K. pneumoniae strains that cause pyogenic liver abscesses. (allC) allantoate amidohydrolase [Allantion utilization (VF0572) - Nutritional/Metabolic factor (VFC0272)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] Klebsiella pneumoniae
CP011967.1_2164 93.377 0.0 allB VF0572 Allantion utilization Nutritional/Metabolic factor VFC0272 An allantoin utilization operon has been associated with hypervirulent K. pneumoniae strains that cause pyogenic liver abscesses. (allB) allantoinase [Allantion utilization (VF0572) - Nutritional/Metabolic factor (VFC0272)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] Klebsiella pneumoniae
CP011967.1_2171 85.874 9.99E-177 allR VF0572 Allantion utilization Nutritional/Metabolic factor VFC0272 An allantoin utilization operon has been associated with hypervirulent K. pneumoniae strains that cause pyogenic liver abscesses. (allR) DNA-binding transcriptional repressor AllR [Allantion utilization (VF0572) - Nutritional/Metabolic factor (VFC0272)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] Klebsiella pneumoniae
CP011967.1_2172 78.75 1.05E-94 allA VF0572 Allantion utilization Nutritional/Metabolic factor VFC0272 An allantoin utilization operon has been associated with hypervirulent K. pneumoniae strains that cause pyogenic liver abscesses. (allA) ureidoglycolate hydrolase [Allantion utilization (VF0572) - Nutritional/Metabolic factor (VFC0272)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] Klebsiella pneumoniae
CP011967.1_2173 73.77 4.84E-172 allS VF0572 Allantion utilization Nutritional/Metabolic factor VFC0272 An allantoin utilization operon has been associated with hypervirulent K. pneumoniae strains that cause pyogenic liver abscesses. (allS) DNA-binding transcriptional activator AllS [Allantion utilization (VF0572) - Nutritional/Metabolic factor (VFC0272)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] Klebsiella pneumoniae
CP011967.1_2212 85.025 0.0 acrA VF0568 AcrAB Antimicrobial activity/Competitive advantage VFC0325 (acrA) acriflavine resistance protein A [AcrAB (VF0568) - Antimicrobial activity/Competitive advantage (VFC0325)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] Klebsiella pneumoniae
CP011967.1_2213 91.992 0.0 acrB VF0568 AcrAB Antimicrobial activity/Competitive advantage VFC0325 (acrB) acriflavine resistance protein B [AcrAB (VF0568) - Antimicrobial activity/Competitive advantage (VFC0325)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] Klebsiella pneumoniae
CP011967.1_2238 65.979 1.38E-97 clpP VF0074 ClpP Stress survival VFC0282 21.6 kDa protein belongs to a family of proteases highly conserved in prokaryotes and eukaryotes (clpP) ATP-dependent Clp protease proteolytic subunit [ClpP (VF0074) - Stress survival (VFC0282)] [Listeria monocytogenes EGD-e] Listeria monocytogenes
CP011967.1_2348 79.167 2.31E-70 gtrA VF0124 LPS Immune modulation VFC0258 Composed of the O-antigen, core polysaccharides and lipid A; the genes involved in the biosynthesis of the basic O-antigen are located in the rfb/rfc loci; O-antigen modification is associated with temperate bacteriophages. Four different serotype-converting phages have been found: SfII, Sf6, SfV and SfX, which are involved in conversion of a serotype Y stain to serotypes 2a, 3b, 5a and X, respectively (gtrA) bactoprenol-linked glucose translocase/flippase [LPS (VF0124) - Immune modulation (VFC0258)] [Shigella flexneri 2a str. 301] Shigella flexneri
CP011967.1_2349 89.109 0.0 gtrB VF0124 LPS Immune modulation VFC0258 Composed of the O-antigen, core polysaccharides and lipid A; the genes involved in the biosynthesis of the basic O-antigen are located in the rfb/rfc loci; O-antigen modification is associated with temperate bacteriophages. Four different serotype-converting phages have been found: SfII, Sf6, SfV and SfX, which are involved in conversion of a serotype Y stain to serotypes 2a, 3b, 5a and X, respectively (gtrB) bactoprenol glucosyl transferase [LPS (VF0124) - Immune modulation (VFC0258)] [Shigella flexneri 2a str. 301] Shigella flexneri
CP011967.1_2420 76.042 9.67E-111 gmhA/lpcA VF0044 LOS Immune modulation VFC0258 Lic1A (phosphorylcholine (ChoP) kinase) 5'-CAAT-3' within the 5'-end of its coding sequence; lic2A, also referred to as lexA, variation in the number of 5'-CAAT-3' repeats has been shown to correlate directly with phase variation of the Gal-alpha(1-4)beta-Gal LPS structure; But lgtC (glycosyltransferase), another phase-variable gene, ultimately dictates whether this structure is synthesized. lic3A encode a sialyl transferase which directs the substitution of LPS with sialic acid. (gmhA/lpcA) phosphoheptose isomerase [LOS (VF0044) - Immune modulation (VFC0258)] [Haemophilus influenzae Rd KW20] Haemophilus influenzae
CP011967.1_2424 99.582 9.5E-178 pagN VF0968 PagN Invasion VFC0083 Unlike rck, pagN is encoded on bacterial chromosome.;PagN is well conserved and widely distributed among the different species and subspecies of Salmonella.;PagN protein displays similarity to the Hek and Tia invasins/adhesins of pathogenic E. coli (pagN) outer membrane adhesin/invasin protein [PagN (VF0968) - Invasion (VFC0083)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2449 79.416 0.0 vgrG VF0974 SCI (Salmonella centrisome island)/SPI-6 T6SS Effector delivery system VFC0086 "The T6SS is widely distributed in all Salmonella species and subspecies.; Salmonella T6SSs are located on five different Salmonella pathogenicity island and phylogenetically belong to i1,
CP011967.1_2456 98.824 0.0 STM0286 VF0974 SCI (Salmonella centrisome island)/SPI-6 T6SS Effector delivery system VFC0086 "The T6SS is widely distributed in all Salmonella species and subspecies.; Salmonella T6SSs are located on five different Salmonella pathogenicity island and phylogenetically belong to i1,
CP011967.1_2457 99.302 0.0 STM0285 VF0974 SCI (Salmonella centrisome island)/SPI-6 T6SS Effector delivery system VFC0086 "The T6SS is widely distributed in all Salmonella species and subspecies.; Salmonella T6SSs are located on five different Salmonella pathogenicity island and phylogenetically belong to i1,
CP011967.1_2458 99.153 9.4E-80 STM0284 VF0974 SCI (Salmonella centrisome island)/SPI-6 T6SS Effector delivery system VFC0086 "The T6SS is widely distributed in all Salmonella species and subspecies.; Salmonella T6SSs are located on five different Salmonella pathogenicity island and phylogenetically belong to i1,
CP011967.1_2459 84.436 1.76E-168 STM0283 VF0974 SCI (Salmonella centrisome island)/SPI-6 T6SS Effector delivery system VFC0086 "The T6SS is widely distributed in all Salmonella species and subspecies.; Salmonella T6SSs are located on five different Salmonella pathogenicity island and phylogenetically belong to i1,
CP011967.1_2460 100.0 0.0 STM0282 VF0974 SCI (Salmonella centrisome island)/SPI-6 T6SS Effector delivery system VFC0086 "The T6SS is widely distributed in all Salmonella species and subspecies.; Salmonella T6SSs are located on five different Salmonella pathogenicity island and phylogenetically belong to i1,
CP011967.1_2461 100.0 0.0 tssK VF0974 SCI (Salmonella centrisome island)/SPI-6 T6SS Effector delivery system VFC0086 "The T6SS is widely distributed in all Salmonella species and subspecies.; Salmonella T6SSs are located on five different Salmonella pathogenicity island and phylogenetically belong to i1,
CP011967.1_2462 98.315 1.55E-129 tssJ VF0974 SCI (Salmonella centrisome island)/SPI-6 T6SS Effector delivery system VFC0086 "The T6SS is widely distributed in all Salmonella species and subspecies.; Salmonella T6SSs are located on five different Salmonella pathogenicity island and phylogenetically belong to i1,
CP011967.1_2463 99.379 2.65E-119 STM0279 VF0974 SCI (Salmonella centrisome island)/SPI-6 T6SS Effector delivery system VFC0086 "The T6SS is widely distributed in all Salmonella species and subspecies.; Salmonella T6SSs are located on five different Salmonella pathogenicity island and phylogenetically belong to i1,
CP011967.1_2464 100.0 1.05E-80 STM0278 VF0974 SCI (Salmonella centrisome island)/SPI-6 T6SS Effector delivery system VFC0086 "The T6SS is widely distributed in all Salmonella species and subspecies.; Salmonella T6SSs are located on five different Salmonella pathogenicity island and phylogenetically belong to i1,
CP011967.1_2465 98.137 7.52E-118 tae4 VF1195 SCI T6SS secreted effectors Effector delivery system VFC0086 (tae4) type VI secretion system effector tae4, L,D-endopeptidase [SCI T6SS secreted effectors (VF1195) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2466 95.031 6.55E-116 STM0276 VF0974 SCI (Salmonella centrisome island)/SPI-6 T6SS Effector delivery system VFC0086 "The T6SS is widely distributed in all Salmonella species and subspecies.; Salmonella T6SSs are located on five different Salmonella pathogenicity island and phylogenetically belong to i1,
CP011967.1_2469 99.602 0.0 STM0274 VF0974 SCI (Salmonella centrisome island)/SPI-6 T6SS Effector delivery system VFC0086 "The T6SS is widely distributed in all Salmonella species and subspecies.; Salmonella T6SSs are located on five different Salmonella pathogenicity island and phylogenetically belong to i1,
CP011967.1_2470 99.444 6.28E-130 STM0273 VF0974 SCI (Salmonella centrisome island)/SPI-6 T6SS Effector delivery system VFC0086 "The T6SS is widely distributed in all Salmonella species and subspecies.; Salmonella T6SSs are located on five different Salmonella pathogenicity island and phylogenetically belong to i1,
CP011967.1_2473 98.63 0.0 STM0272 VF0974 SCI (Salmonella centrisome island)/SPI-6 T6SS Effector delivery system VFC0086 "The T6SS is widely distributed in all Salmonella species and subspecies.; Salmonella T6SSs are located on five different Salmonella pathogenicity island and phylogenetically belong to i1,
CP011967.1_2474 100.0 2.8E-125 STM0271 VF0974 SCI (Salmonella centrisome island)/SPI-6 T6SS Effector delivery system VFC0086 "The T6SS is widely distributed in all Salmonella species and subspecies.; Salmonella T6SSs are located on five different Salmonella pathogenicity island and phylogenetically belong to i1,
CP011967.1_2475 98.413 3.45E-89 STM0271 VF0974 SCI (Salmonella centrisome island)/SPI-6 T6SS Effector delivery system VFC0086 "The T6SS is widely distributed in all Salmonella species and subspecies.; Salmonella T6SSs are located on five different Salmonella pathogenicity island and phylogenetically belong to i1,
CP011967.1_2476 99.27 0.0 STM0270 VF0974 SCI (Salmonella centrisome island)/SPI-6 T6SS Effector delivery system VFC0086 "The T6SS is widely distributed in all Salmonella species and subspecies.; Salmonella T6SSs are located on five different Salmonella pathogenicity island and phylogenetically belong to i1,
CP011967.1_2477 99.39 1.29E-120 STM0269 VF0974 SCI (Salmonella centrisome island)/SPI-6 T6SS Effector delivery system VFC0086 "The T6SS is widely distributed in all Salmonella species and subspecies.; Salmonella T6SSs are located on five different Salmonella pathogenicity island and phylogenetically belong to i1,
CP011967.1_2478 99.681 0.0 STM0268 VF0974 SCI (Salmonella centrisome island)/SPI-6 T6SS Effector delivery system VFC0086 "The T6SS is widely distributed in all Salmonella species and subspecies.; Salmonella T6SSs are located on five different Salmonella pathogenicity island and phylogenetically belong to i1,
CP011967.1_2479 99.698 0.0 STM0267 VF0974 SCI (Salmonella centrisome island)/SPI-6 T6SS Effector delivery system VFC0086 "The T6SS is widely distributed in all Salmonella species and subspecies.; Salmonella T6SSs are located on five different Salmonella pathogenicity island and phylogenetically belong to i1,
CP011967.1_2480 98.006 0.0 STM0266 VF0974 SCI (Salmonella centrisome island)/SPI-6 T6SS Effector delivery system VFC0086 "The T6SS is widely distributed in all Salmonella species and subspecies.; Salmonella T6SSs are located on five different Salmonella pathogenicity island and phylogenetically belong to i1,
CP011967.1_2518 98.483 0.0 bapA VF0971 BapA Adherence VFC0001 "
CP011967.1_2530 69.198 8.14E-123 sopE2 VF0949 TTSS-1 secreted effectors Effector delivery system VFC0086 (sopE2) type III secretion system effector SopE2, guanine nucleotide exchange factor [TTSS-1 secreted effectors (VF0949) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2609 86.792 0.0 iroB VF0230 Salmochelin siderophore Nutritional/Metabolic factor VFC0272 Also identified as virulence factors in extracellular pathogenic Escherichia coli and Salmonella enterica serotype Typhi (iroB) glucosyltransferase IroB [Salmochelin siderophore (VF0230) - Nutritional/Metabolic factor (VFC0272)] [Escherichia coli CFT073] Escherichia coli (UPEC)
CP011967.1_2610 81.886 0.0 iroC VF0563 Sal Nutritional/Metabolic factor VFC0272 Salmochelin is a glycosylated Ent that requires the iroA locus for production and transport (iroC) ABC transporter [Sal (VF0563) - Nutritional/Metabolic factor (VFC0272)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] Klebsiella pneumoniae
CP011967.1_2611 68.861 0.0 iroD VF0230 Salmochelin siderophore Nutritional/Metabolic factor VFC0272 Also identified as virulence factors in extracellular pathogenic Escherichia coli and Salmonella enterica serotype Typhi (iroD) esterase [Salmochelin siderophore (VF0230) - Nutritional/Metabolic factor (VFC0272)] [Escherichia coli CFT073] Escherichia coli (UPEC)
CP011967.1_2612 61.587 4.87E-131 iroE VF0230 Salmochelin siderophore Nutritional/Metabolic factor VFC0272 Also identified as virulence factors in extracellular pathogenic Escherichia coli and Salmonella enterica serotype Typhi (iroE) esterase [Salmochelin siderophore (VF0230) - Nutritional/Metabolic factor (VFC0272)] [Escherichia coli CFT073] Escherichia coli (UPEC)
CP011967.1_2613 83.84 0.0 iroN VF0563 Sal Nutritional/Metabolic factor VFC0272 Salmochelin is a glycosylated Ent that requires the iroA locus for production and transport (iroN) salmochelin receptor IroN [Sal (VF0563) - Nutritional/Metabolic factor (VFC0272)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] Klebsiella pneumoniae
CP011967.1_2615 98.0 0.0 pipB2 VF0947 TTSS-2 secreted effectors Effector delivery system VFC0086 (pipB2) type III secretion system effector PipB3 [TTSS-2 secreted effectors (VF0947) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2617 98.322 0.0 mig-14 VF0395 Mig-14 Antimicrobial activity/Competitive advantage VFC0325 Mig-14 expression is induced within macrophages and is under the control of the global regulator PhoP (mig-14) antimicrobial peptide resistance protein Mig-14 [Mig-14 (VF0395) - Antimicrobial activity/Competitive advantage (VFC0325)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2655 71.93 2.39E-93 luxS VF0406 AI-2 Biofilm VFC0271 AI-2 is produced and detected by a wide variety of bacteria and is presumed to facilitate interspecies communications. (luxS) S-ribosylhomocysteinase [AI-2 (VF0406) - Biofilm (VFC0271)] [Vibrio cholerae O1 biovar El Tor str. N16961] Vibrio cholerae
CP011967.1_2659 76.667 1.4E-30 csrA VF0261 CsrA Regulation VFC0301 Belongs to a highly conserved family of global regulators that typically control stationary phase traits post-transcriptionally (csrA) carbon storage regulator CsrA [CsrA (VF0261) - Regulation (VFC0301)] [Legionella pneumophila subsp. pneumophila str. Philadelphia 1] Legionella pneumophila
CP011967.1_2699 98.406 0.0 sprB VF0116 TTSS (SPI-1 encode) Effector delivery system VFC0086 (sprB) transcriptional regulator [TTSS (SPI-1 encode) (VF0116) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2700 99.661 0.0 hilC VF0116 TTSS (SPI-1 encode) Effector delivery system VFC0086 (hilC) AraC family transcriptional regulator [TTSS (SPI-1 encode) (VF0116) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2701 98.0 1.22E-108 orgC VF0116 TTSS (SPI-1 encode) Effector delivery system VFC0086 (orgC) type III secretion system effector OrgC [TTSS (SPI-1 encode) (VF0116) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2702 100.0 1.82E-169 orgB/SctL VF0116 TTSS (SPI-1 encode) Effector delivery system VFC0086 (orgB/SctL) type III secretion system stator OrgB [TTSS (SPI-1 encode) (VF0116) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2703 100.0 8.49E-141 orgA/sctK VF0116 TTSS (SPI-1 encode) Effector delivery system VFC0086 (orgA/sctK) type III secretion system accessory cytosolic protein OrgA [TTSS (SPI-1 encode) (VF0116) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2704 100.0 0.0 prgK VF0116 TTSS (SPI-1 encode) Effector delivery system VFC0086 (prgK) type III secretion system inner MS ring protein PrgK [TTSS (SPI-1 encode) (VF0116) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2705 100.0 4.28E-70 prgJ VF0116 TTSS (SPI-1 encode) Effector delivery system VFC0086 (prgJ) type III secretion system inner rod protein PrgJ [TTSS (SPI-1 encode) (VF0116) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2706 96.25 1.79E-53 prgI VF0116 TTSS (SPI-1 encode) Effector delivery system VFC0086 (prgI) type III secretion system needle filament protein PrgI [TTSS (SPI-1 encode) (VF0116) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2707 99.49 0.0 prgH VF0116 TTSS (SPI-1 encode) Effector delivery system VFC0086 (prgH) type III secretion system outer MS ring protein PrgH [TTSS (SPI-1 encode) (VF0116) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2708 100.0 0.0 hilD VF0116 TTSS (SPI-1 encode) Effector delivery system VFC0086 (hilD) AraC family transcriptional regulator [TTSS (SPI-1 encode) (VF0116) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2709 99.819 0.0 hilA VF0116 TTSS (SPI-1 encode) Effector delivery system VFC0086 (hilA) transcriptional regulator [TTSS (SPI-1 encode) (VF0116) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2710 98.75 9.91E-118 iagB VF0116 TTSS (SPI-1 encode) Effector delivery system VFC0086 (iagB) invasion protein IagB [TTSS (SPI-1 encode) (VF0116) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2711 94.019 0.0 sptP VF0949 TTSS-1 secreted effectors Effector delivery system VFC0086 (sptP) type III secretion system effector SptP, tyrosine phosphatase and GTPase-activating protein [TTSS-1 secreted effectors (VF0949) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2712 97.692 1.88E-91 sicP VF0116 TTSS (SPI-1 encode) Effector delivery system VFC0086 (sicP) chaparone for SptP [TTSS (SPI-1 encode) (VF0116) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2714 98.78 4.73E-55 iacP VF0116 TTSS (SPI-1 encode) Effector delivery system VFC0086 (iacP) putative acyl carrier protein [TTSS (SPI-1 encode) (VF0116) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2715 97.664 0.0 sipA/sspA VF0949 TTSS-1 secreted effectors Effector delivery system VFC0086 (sipA/sspA) type III secretion system effector SipA (Salmonella invasion protein A) [TTSS-1 secreted effectors (VF0949) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2716 87.172 0.0 sipD VF0116 TTSS (SPI-1 encode) Effector delivery system VFC0086 (sipD) type III secretion system hydrophilic translocator, needle tip protein SipD [TTSS (SPI-1 encode) (VF0116) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2717 99.511 0.0 sipC/sspC VF0116 TTSS (SPI-1 encode) Effector delivery system VFC0086 (sipC/sspC) type III secretion system hydrophilic translocator, pore protein SipC [TTSS (SPI-1 encode) (VF0116) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2718 99.663 0.0 sipB/sspB VF0116 TTSS (SPI-1 encode) Effector delivery system VFC0086 (sipB/sspB) type III secretion system hydrophilic translocator, pore protein SipB (Salmonella invasion protein B) [TTSS (SPI-1 encode) (VF0116) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2719 100.0 1.17E-124 sicA VF0116 TTSS (SPI-1 encode) Effector delivery system VFC0086 (sicA) chaparone for SipC and SipB [TTSS (SPI-1 encode) (VF0116) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2720 99.438 0.0 spaS VF0116 TTSS (SPI-1 encode) Effector delivery system VFC0086 (spaS) type III secretion system export apparatus switch protein SpaS [TTSS (SPI-1 encode) (VF0116) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2721 99.62 0.0 spaR VF0116 TTSS (SPI-1 encode) Effector delivery system VFC0086 (spaR) type III secretion system minor export apparatus protein SpaR [TTSS (SPI-1 encode) (VF0116) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2722 100.0 1.03E-56 spaQ VF0116 TTSS (SPI-1 encode) Effector delivery system VFC0086 (spaQ) type III secretion system minor export apparatus protein SpaQ [TTSS (SPI-1 encode) (VF0116) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2723 99.554 1.34E-164 spaP VF0116 TTSS (SPI-1 encode) Effector delivery system VFC0086 (spaP) type III secretion system minor export apparatus protein SpaP [TTSS (SPI-1 encode) (VF0116) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2724 99.67 0.0 spaO/sctQ VF0116 TTSS (SPI-1 encode) Effector delivery system VFC0086 (spaO/sctQ) type III secretion system C ring protein SpaO [TTSS (SPI-1 encode) (VF0116) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2725 98.81 0.0 invJ VF0116 TTSS (SPI-1 encode) Effector delivery system VFC0086 (invJ) type III secretion system needle length regulator InvJ [TTSS (SPI-1 encode) (VF0116) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2726 99.32 2.44E-99 invI VF0116 TTSS (SPI-1 encode) Effector delivery system VFC0086 (invI) type III secretion system stalk protein InvI [TTSS (SPI-1 encode) (VF0116) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2727 99.768 0.0 invC/sctN VF0116 TTSS (SPI-1 encode) Effector delivery system VFC0086 (invC/sctN) type III secretion system ATPase InvC [TTSS (SPI-1 encode) (VF0116) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2728 99.259 7.0E-98 invB VF0116 TTSS (SPI-1 encode) Effector delivery system VFC0086 (invB) type III secretion system protein InvB [TTSS (SPI-1 encode) (VF0116) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2729 100.0 0.0 invA VF0116 TTSS (SPI-1 encode) Effector delivery system VFC0086 (invA) type III secretion system major export apparatus protein InvA [TTSS (SPI-1 encode) (VF0116) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2730 99.731 0.0 invE VF0116 TTSS (SPI-1 encode) Effector delivery system VFC0086 (invE) type III secretion system gatekeeper invE [TTSS (SPI-1 encode) (VF0116) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2731 99.644 0.0 invG VF0116 TTSS (SPI-1 encode) Effector delivery system VFC0086 (invG) type III secretion system secretin invG [TTSS (SPI-1 encode) (VF0116) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2732 100.0 1.76E-163 invF VF0116 TTSS (SPI-1 encode) Effector delivery system VFC0086 (invF) type III secretion system regulatory protein InvF [TTSS (SPI-1 encode) (VF0116) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2733 99.32 2.83E-106 invH VF0116 TTSS (SPI-1 encode) Effector delivery system VFC0086 (invH) type III secretion system pilotin invG [TTSS (SPI-1 encode) (VF0116) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2752 100.0 0.0 rpoS VF0112 RpoS Regulation VFC0301 (rpoS) RNA polymerase sigma factor RpoS [RpoS (VF0112) - Regulation (VFC0301)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2777 97.792 0.0 sopD VF0949 TTSS-1 secreted effectors Effector delivery system VFC0086 (sopD) type III secretion system effector SopD [TTSS-1 secreted effectors (VF0949) - Effector delivery system (VFC0086)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_2962 60.0 3.51E-71 hcp/tssD VF0944 HSI-3 Effector delivery system VFC0086 The expression of T6SSs in P. aeruginosa is regulated by the QS system. There are several QS systems in P. aeruginosa, two N-acyl-homoserine lactone based QS systems (las and rhl systems) and one quinolone PQS system (pqs). The expression of H1-T6SS is negatively regulated by both las and pqs QS systems, while the expression of H2- and H3-T6SS is positively regulated by las, rhl, and pqs (hcp/tssD) Hcp family type VI secretion system effector [HSI-3 (VF0944) - Effector delivery system (VFC0086)] [Pseudomonas aeruginosa PAO1] Pseudomonas aeruginosa
CP011967.1_3034 69.892 0.0 rfaE VF0044 LOS Immune modulation VFC0258 Lic1A (phosphorylcholine (ChoP) kinase) 5'-CAAT-3' within the 5'-end of its coding sequence; lic2A, also referred to as lexA, variation in the number of 5'-CAAT-3' repeats has been shown to correlate directly with phase variation of the Gal-alpha(1-4)beta-Gal LPS structure; But lgtC (glycosyltransferase), another phase-variable gene, ultimately dictates whether this structure is synthesized. lic3A encode a sialyl transferase which directs the substitution of LPS with sialic acid. (rfaE) ADP-heptose synthase [LOS (VF0044) - Immune modulation (VFC0258)] [Haemophilus influenzae Rd KW20] Haemophilus influenzae
CP011967.1_3218 68.533 0.0 acrA VF0568 AcrAB Antimicrobial activity/Competitive advantage VFC0325 (acrA) acriflavine resistance protein A [AcrAB (VF0568) - Antimicrobial activity/Competitive advantage (VFC0325)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] Klebsiella pneumoniae
CP011967.1_3219 80.845 0.0 acrB VF0568 AcrAB Antimicrobial activity/Competitive advantage VFC0325 (acrB) acriflavine resistance protein B [AcrAB (VF0568) - Antimicrobial activity/Competitive advantage (VFC0325)] [Klebsiella pneumoniae subsp. pneumoniae NTUH-K2044] Klebsiella pneumoniae
CP011967.1_3268 80.153 0.0 tufA VF0460 EF-Tu Adherence VFC0001 (tufA) elongation factor Tu [EF-Tu (VF0460) - Adherence (VFC0001)] [Francisella tularensis subsp. tularensis SCHU S4] Francisella tularensis
CP011967.1_3289 66.832 1.99E-99 vfr VF0082 Type IV pili Adherence VFC0001 PilA, B, C, D, E, F, M, N, O, P, Q, T, U, V, W, X, Y1, Y2, Z, and fimT, U, V are involved in the biogenesis and mechanical function of pili, pilG, H, I, K, chpA, B, C, D, E, pilS, R, fimS, rpoN, algR, algU, and vfr are involved in transcriptional regulation and chemosensory pathways that control the expression or activity of the twitching motility of the pili (vfr) cAMP-regulatory protein [Type IV pili (VF0082) - Adherence (VFC0001)] [Pseudomonas aeruginosa PAO1] Pseudomonas aeruginosa
CP011967.1_3305 63.964 7.82E-102 rpe VF0543 Capsule Immune modulation VFC0258 Group 4 capsule; high molecular weight (HMW) O-antigen capsule (rpe) ribulose-phosphate 3-epimerase [Capsule (VF0543) - Immune modulation (VFC0258)] [Francisella tularensis subsp. tularensis SCHU S4] Francisella tularensis
CP011967.1_3523 77.922 0.0 rfaD VF0044 LOS Immune modulation VFC0258 Lic1A (phosphorylcholine (ChoP) kinase) 5'-CAAT-3' within the 5'-end of its coding sequence; lic2A, also referred to as lexA, variation in the number of 5'-CAAT-3' repeats has been shown to correlate directly with phase variation of the Gal-alpha(1-4)beta-Gal LPS structure; But lgtC (glycosyltransferase), another phase-variable gene, ultimately dictates whether this structure is synthesized. lic3A encode a sialyl transferase which directs the substitution of LPS with sialic acid. (rfaD) ADP-L-glycero-D-mannoheptose-6-epimerase [LOS (VF0044) - Immune modulation (VFC0258)] [Haemophilus influenzae Rd KW20] Haemophilus influenzae
CP011967.1_3524 63.714 1.84E-157 rfaF VF0044 LOS Immune modulation VFC0258 Lic1A (phosphorylcholine (ChoP) kinase) 5'-CAAT-3' within the 5'-end of its coding sequence; lic2A, also referred to as lexA, variation in the number of 5'-CAAT-3' repeats has been shown to correlate directly with phase variation of the Gal-alpha(1-4)beta-Gal LPS structure; But lgtC (glycosyltransferase), another phase-variable gene, ultimately dictates whether this structure is synthesized. lic3A encode a sialyl transferase which directs the substitution of LPS with sialic acid. (rfaF) ADP-heptose-LPS heptosyltransferase II [LOS (VF0044) - Immune modulation (VFC0258)] [Haemophilus influenzae Rd KW20] Haemophilus influenzae
CP011967.1_3572 98.115 0.0 misL VF0397 MisL Adherence VFC0001 MisL is located within Salmonella Pathogenicity Island SPI-3 (misL) putative autotransporter [MisL (VF0397) - Adherence (VFC0001)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_3578 99.559 0.0 mgtB VF0106 MgtB Nutritional/Metabolic factor VFC0272 A magnesium transporter (mgtB) Mg2+ transport protein [MgtB (VF0106) - Nutritional/Metabolic factor (VFC0272)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_3579 98.678 1.34E-165 mgtC VF1365 MgtC Nutritional/Metabolic factor VFC0272 An inner membrane protein; anti-virulence protein CigR inhibits the virulence functions of MgtC at early times inside macrophages (mgtC) Salmonella virulence protein MgtC [MgtC (VF1365) - Nutritional/Metabolic factor (VFC0272)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_3728 64.881 1.22E-168 rffG VF0044 LOS Immune modulation VFC0258 Lic1A (phosphorylcholine (ChoP) kinase) 5'-CAAT-3' within the 5'-end of its coding sequence; lic2A, also referred to as lexA, variation in the number of 5'-CAAT-3' repeats has been shown to correlate directly with phase variation of the Gal-alpha(1-4)beta-Gal LPS structure; But lgtC (glycosyltransferase), another phase-variable gene, ultimately dictates whether this structure is synthesized. lic3A encode a sialyl transferase which directs the substitution of LPS with sialic acid. (rffG) dTDP-glucose 46-dehydratase [LOS (VF0044) - Immune modulation (VFC0258)] [Haemophilus influenzae Rd KW20] Haemophilus influenzae
CP011967.1_3729 66.323 4.11E-142 wbtL VF0542 LPS Immune modulation VFC0258 The structure of Francisella spp. lipid A is unique in that it is modified by various carbohydrates that greatly reduce TLR4 activation and allow for immune evasion (wbtL) glucose-1-phosphate thymidylyltransferase [LPS (VF0542) - Immune modulation (VFC0258)] [Francisella tularensis subsp. tularensis SCHU S4] Francisella tularensis
CP011967.1_3918 88.908 0.0 ibeC VF0237 Ibes Invasion VFC0083 IbeA is unique to E. coli K1. The ibeB and ibeC are found to have K12 homologues p77211 and yijP respectively. (ibeC) phosphoethanolamine transferase CptA [Ibes (VF0237) - Invasion (VFC0083)] [Escherichia coli O45:K1:H7 str. S88] Escherichia coli (NMEC)
CP011967.1_3935 80.153 0.0 tufA VF0460 EF-Tu Adherence VFC0001 (tufA) elongation factor Tu [EF-Tu (VF0460) - Adherence (VFC0001)] [Francisella tularensis subsp. tularensis SCHU S4] Francisella tularensis
CP011967.1_3969 61.827 0.0 icl VF0253 Isocitrate lyase Others VFC0346 (icl) Isocitrate lyase Icl (isocitrase) (isocitratase) [Isocitrate lyase (VF0253) - Others (VFC0346)] [Mycobacterium tuberculosis H37Rv] Mycobacterium tuberculosis
CP011967.1_4024 82.148 0.0 siiE VF0970 SiiE Adherence VFC0001 SiiE is located within Salmonella Pathogenicity Island SPI-4, a 27-kb region that carries six genes designated siiABCDEF. SiiC, SiiD, and SiiF form a type I secretion apparatus for the secretion of SiiE.;With 595 kDa, SiiE is the largest protein of the Salmonella proteome.;SiiE, like many other non-fimbrial adhesins binds to glycostructures at the cell surface. (siiE) non-fimbrial adhesin SiiE [SiiE (VF0970) - Adherence (VFC0001)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_4056 98.315 0.0 pmrB VF1355 PmrAB Regulation VFC0301 (pmrB) sensory kinase PmrB [PmrAB (VF1355) - Regulation (VFC0301)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_4057 99.55 1.17E-164 pmrA VF1355 PmrAB Regulation VFC0301 (pmrA) response regulator PmrA [PmrAB (VF1355) - Regulation (VFC0301)] [Salmonella enterica subsp. enterica serovar Typhimurium str. LT2] Salmonella enterica (serovar typhimurium)
CP011967.1_4092 75.758 0.0 htpB VF0159 Hsp60 Adherence VFC0001 (htpB) Hsp60, 60K heat shock protein HtpB [Hsp60 (VF0159) - Adherence (VFC0001)] [Legionella pneumophila subsp. pneumophila str. Philadelphia 1] Legionella pneumophila
CP011967.1_4295 72.172 0.0 cheD VF0394 Flagella Motility VFC0204 (cheD) methyl-accepting chemotaxis protein CheD [Flagella (VF0394) - Motility (VFC0204)] [Yersinia enterocolitica subsp. enterocolitica 8081] Yersinia enterocolitica